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Abstract

A COMPARATIVE STUDY OF MURINE MAST CELL PROGENITORS
By Shirley K DeSimone, B.A., M.A., M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2001
Director: Thomas F. Huff, Ph.D., Professor, Department of Microbiology and
Immunology
This thesis is a comparative study of variables affecting differentiation and proliferation of
progenitor cells from various embryonic and fetal tissue sites as they differentiate into mast
cells. Embryonic stem cells from gestation day 4.5 (d4.5) differentiated exclusively into
mast cells when cultured in semi-solid media with stem cell factor (SCF) and Interleukin-3
(IL-3). The same was true of d8-1 1 yolk sac cells and d8-1 1 cells from the embryo itself.
However, culture with SCF and IL-3 of cells from dl4 fetal livers differentiated into mast
cells, cells of the erythrocyte lineage and a few "macrophages" which may have been similar
to the stromal cell found in the bone marrow that supplies iron to and removes the nucleus
from erythrocytes. An erythrocyte-nurturing role for the fetal liver "macrophages" was
substantiated by removing cells expressing Mac!, and sorting for cells expressing the early
mast cell marker, Kit, resulting in cells that differentiated only into mast cells with SCF and
IL-3. The variables affecting proliferation that were studied were brief incubation at very
high cell density, and co-culture with fibroblasts. In addition, a few experiments were done
to determine the mechanism of the effect of these variables on proliferation. High cell
density incubation increased proliferation of yolk sac, fetal liver and bone marrow cells. The

x

increased proliferation of yolk sac and bone marrow cells was attenuated by an inhibitor of
the sodium-ionlhydrogen-ion exchanger, 5-(N,N-hexamethylene) amiloride (HMA). The
exchanger was also found to play a role in the subsequent proliferation of mast cells from
bone marrow cells co-cultured with fibroblasts since, if HMA was present during the first
thirty minutes of contact, mast cell proliferation decreased by 75%. Using fluorescent
imaging, activation of this exchanger was monitored by an increase in intracellular pH.
Altogether these results demonstrate a growing concept in developmental biology regarding
the normal stem cell in its niche (tissue site) and the affects of exogenous variables on it.
They substantiate the concept that the differentiation path and proliferation of a stem cell
depends both on its past history and on its future circumstances.

Introduction
Distribution of Mast Cells in the Adult and Embryo. Ever since Paul Ehrlich

studied mast cells in the 1 870s, it has been well established that they are ubiquitously
distributed in most adult tissues and some bodily fluids. How do mast cells come to be
distributed so widely in the adult body? One source of mast cell progenitors in the adult is
the bone marrow (Kitamura et aI., 1 977). It is thought that the stem cell for mast cells is the
same stem cell that gives rise to hemopoietic cells. Like some other immature hemopoietic
cell progenitors, ungranulated mast cell progenitors are thought to arise from bone marrow
stem cells and to migrate to other tissue sites where they become functionally mature
granulated cells. Thus the BM is the source of mast cell progenitors and the blood is the
means of distribution to the many sites in the adult. How does the BM come to contain
progenitor cells for mast cells? The BM is one of the last organized tissues to form in the
developing embryo. However, stem cells from earlier embryological structures form mast
cells.

The current knowledge of mast cell ontogeny involves several embryological

structures: the inner cell mass, the yolk sac, the fetal liver, the para-aortic splanchnopleura,
the aorta-gonadal mesonephros, and the blood. In addition, several signal transduction
molecules are known to be involved in mast cell ontogeny.
Embryonic Development ofStem Cells, Yolk Sac cells and Fetal Liver Cells. The

first 20% of a mouse's embryonic life consists of successive division of a fertilized ovum,
resulting in a spherical "inner cell mass" each cell of which is maximally totipotential, i.e.,
each cell can regenerate the entire organism. This is shown by removing the inner cell mass
at four and a half days of gestation and culturing these cells, called "embryonic stem cells"

in vitro to form cells of various tissues, including hemopoietic and mast cells. In vivo, in
order for these single cells to form a multi-cellular organism of differentiated cells, both
"adhesion" molecules and a means of communication between the cells are necessary. First
to form around the sphere of cells that comprise the inner cell mass is an outer epithelial
sheet held together via tight junctions, inside of which are cells electrically coupled via gap
junctions. On the inside face of the epithelial lining, a fibronectin-rich matrix is secreted.
Also inside this spherical blastula is a cavity of isotonic saline. Some ventral pole cells lose
their propensity to stick to cells of their own kind and develop adhesion molecules with an
affinity for the extracellular fibronectin matrix. These primary mesenchymal cells crawl over
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the inner face of the epithelial lining. Simultaneously, epithelial cells, close to the point of
mesenchymal cell generation, begin to tuck inward. These invaginating cells continue to
extend to the animal pole, forming the gut tube. The primary mesenchymal cells are trapped
between the gut tube and the outer wall to become the mesoderm (Alberts et ai., 1 989).
The process of formation of these three tissue structures, ectoderm, mesoderm, and
endoderm, is called gastrulation. Cells become determined sometime between the early and
late gastrula stages.

Some of the mesoderm segments into somites, "pinched off"

independent cell masses that develop into central cavities that are enlarged to form the
abdominal and thoracic cavities and from which cells migrate out to form muscles. The
more peripheral, unsegmented mesoderm becomes connective tissue, including the dermis
and the vascular system. At some point, some mesenchymal cells are destined to become
hemopoietic (and mast cell) stem cells. Classically, when the first site of appearance of
hemopoietic stem cells was sought, investigators were attracted to the extra-embryonic yolk
sac due to the early presence of microscopically visible blood islands and, later in gestation,
to the fetal liver, also due to its visible blood.
In a mammal such as a mouse, the yolk sac is formed subsequent to the posterior
mesoderm proliferating extra-embryonically and forming a layer interior to the endoderm.
When the amniotic wall is formed, the embryonic cylinder is divided into the embryo proper
and the extra-embryonic yolk sac (some time between 7.5 and 8.5 days of gestation). The
extra-embryonic mesoderm of the yolk sac produces most of the membranes that will
eventually surround the embryo, and also produces the first hemopoietic cell site that is
morphologically identifiable, viz., the yolk sac blood islands at 8.5 days. These blood islands
form from aggregates of mesodermal cells and are the sites for generation of rudimentary
nucleated red blood cells containing primitive hemoglobin. Thus, within four days, i.e.since
the formation of the inner cell mass, some cells have become unipotential for the erythroid
lineage. Although other hemopoietic lineages are not present in the yolk sac in situ,
progenitors for the myeloid and the lymphoid lineages can be cultured from the yolk sac, and,
as we have found for the first time, mast cell progenitors can also be cultured from the YS.
Hemopoiesis actually is initiated before 8.5 days of gestation, as shown by the presence of
RNA message for hemopoietic and erythroid gene products at 6.5 and 7.5 days of gestation
(Keller et ai., 1 993; Rich, 1 995; Zimmermann and Rich, 1 997).
Mesodermal cells comprising the outer layer of the blood islands divide and form the
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blood vessels of the primitive circulation. These eventually join the embryonic blood vessels
formed from the more peripheral, unsegmented mesoderm connective tissue (described
above). The heart muscle, which has been forming in the embryo, begins to beat between
9 and 9.5 days. The YS continues to be the primary hemopoietic organ of the mouse embryo
until day 10 or 11 of gestation, when the liver has formed.
Formation of the liver is an instructive example of the importance of cognate
interaction between mesodermal cells and endodermal cells. Induction of the liver gene
expression program appears to be initiated around d8 when a region of the foregut endoderm,
that is in close proximity to the cardiac mesoderm, synthesizes message for liver-specific
proteins due to the prior activation of endodermal cell FGF receptors by mesodermal-cell
membrane FGF. Other fibroblast growth factors contribute to the outgrowth of the hepatic
endoderm into the septum transversum at late d9 (Johnson and Jones, 1 973; Jung et aI.,
1999) It is thought that the liver rudiment does not initiate hemopoiesis in situ, but is
colonized by, and serves as a reservoir of, founder hematopoietic cells generated at earlier
hemopoietic sites within the conceptus (Johnson and Moore, 1 970) (Moore and Metcalf,
1 975).
Because of the appearance of microscopically visible blood islands in the yolk sac
and the later appearance of red blood cells in the fetal liver, the yolk sac and the fetal liver
have classically been the tissues of choice for examining hemopoiesis. The dissection of
these tissues is relatively easy and, when it was discovered that transplantation of bone
marrow stem cells could rescue a lethally irradiated recipient, comparisons were made
between the rescue potential of yolk sac and fetal liver cells and bone marrow cells. It was
discovered that fetal liver cells, like adult bone marrow cells, could rescue an irradiated adult,
but yolk sac cells did not have this rescue potential. The difference in rescue potential
seemed to correlate with morphological and biochemical differences that had been found
between yolk sac erythrocytes and fetal liver erythrocytes:

Yolk sac erythrocytes are

nucleated while fetal liver erythrocytes are enucleated (like adult erythrocytes). Yolk sac
erythrocytes contain hemoglobin whose structure is less efficient for transporting oxygen
than fetal liver erythrocyte hemoglobin. These differences in transplantation rescue potential
and in erythrocyte functionality led to the classification of yolk sac stem cells as "primitive"
and to fetal liver stem cells as "definitive". The prevalent view was that primitive stem cells
first arose in the embryo in the yolk sac. After the liver has formed, it becomes the site of
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definitive blood cell formation through migration of stem cells from the yolk sac. (Note that
the definitive hemopoeitic stem cell gene expression pattern arises after exposure to at least
two microenvironments different from that of the YS, first that ofthe blood and then that of
the FL). Hemopoiesis was subsequently transferred from the fetal liver by migration of stem
'
cells to the bone marrow as the fetus neared birth, when the liver assumed its specialized
biochemical functions.
Mast Cell Ontogeny. Before 1 996, only one report had dealt specifically with mast

cell ontogeny in the embryo. This was an elegant in vivo study in 1 983 that used yolk sac
and fetal liver cells to demonstrate that mast cell ontogeny parallels erythrocyte ontogeny.
This study took advantage of mice called WWV mice that have a natural mutation in the c-kit
gene that causes them both to be deficient in dermal connective tissue mast cells and to be
anemic. Although intravenous injection of wild-type fetal liver cells rescued the dermal mast
cell depletion ofWWv mice, the intravenous inj ection of the same number of wild-type yolk
sac cells did not rescue the dermal mast cell depletion. (Sonoda and Kitumura, 1 983). In a
similar manner, wild-type fetal liver cells cure the anemia ofWWV mice, but wild-type yolk
sac cells do not (Russell and Bernstein, 1 968).
The gene that is mutated in WWv mice, the c-kit gene, codes for Kit, a
transmembrane receptor protein with tyrosine kinase activity. Kit is important in mast cell,
erythrocyte, and primordial germ cell development: mutations in Kit lead to mastopenia,
anemia, and infertility in the adult. Hemopoietic stem cells express Kit, but most lineages,
including the erythrocytic, lose Kit expression as they mature. Mast cells continue to express
Kit throughout their life. Thus Kit expression can be used to separate stem cells from other
cells, and to identify mast cell progenitors (Lantz, 1 995, Rodewald, 1 996). The ligand for
Kit is stem cell factor, a protein found both in a membrane and a secreted form. A few other
mast cell membrane molecules expressed during the differentiation of the mast cell
progenitor have been described.

These include a4Pl ' an integrin and T l , an orphan

membrane receptor.
The Para-aortic Splanchnopleura, the Aorta-gonadal Mesonephros, and the KiF
Progenitor.

The view that the fetal liver is the primary and sole site of definitive

hemopoietic progenitors has been challenged in recent years by findings of definitive
hemopoietic progenitors in the splanchnopleura surrounding the dorsal aorta (P AS) at day
8-9, followed by definitive progenitor cell development in the structures formed from this

region by days 1 0- 1 1 viz, the aorta-gonadal-mesonephros (AGM) (reviewed in Dzierzak,
1 998). This finding completely contradicted the classical concept that definitive hemopoietic
stem cells arose in the fetal liver via migration of stem cells from the yolk sac.
The significance ofthe PAS! AGM findings with respect to mastopoiesis is unknown.
However, the findings that Kit+ cells, found initially in the PAS!AGM region, appear to
migrate through the blood to the fetal liver strongly suggests that a stem cell for mast cells,
like that for definitive hemopoietic cells, arises in the PAS!AGM and migrates via the blood
to the fetal liver (and from the fetal liver, or, independently, to the bone marrow). However
the picture is complicated by observations that other Kit+ precursors from the AGM , such
as melanoblasts and primordial germ cells reach their destination, not by migration via the
blood, but by migration via cells of tissues that express stem cell factor and guide them to
their adult tissue site.
Normal Ontogeny Depends upon Cellular Communication. We havejust described

several examples ofcell-matrix or cell-cell interactions in normal embryo development, e.g.,
expression ofcell adhesion molecules with an affinity for fibronectin during gastrulation, and
cognate interaction between mesodermal cells and endodermal cells during formation of the
liver. Communication from other cells is also important for the hemopoeitic stem cell as
described above for the stem cell migrating into and out of the blood and subsequent
differentiation in the FL and BM. There is also the requirement of a high concentration of
membrane stem cell factor on cells over which Kit' melanoblasts and primordial germ cells
migrate. These examples illustrate the importance of the microenvironment to the normal
development of all embryonic and fetal cells.
This thesis will compare mast cell progenitors arising in the yolk sac, the fetal liver,
and the embryo proper and explore micro environmental factors important for mast cell
development. The identity of some of these factors is known. Prime candidates are the
integrin, a.Pl' and the cytokines, SCF and IL-3. In fact, the effects ofrSCF and rIL-3 on the

in vitro differentiation of mast cell progenitors from adult sites are dependent upon the stage
of maturation of the cells at the time they are exposed to these cytokines (Lantz and Huff,
1 995). We can anticipate, therefore, that micro environmental factors would be instrumental
in differentiation and proliferation of all mast cells progenitors.

Literature Review
Staining Characteristics of Mast Cells. The first report of mast cells as unique

cells characterized as we do today was by Paul Ehrlich who, in 1 878, stained the
connective tissues of various adult vertebrates with a blue aniline dye and was rewarded
by the sight of cells with prominent metachromatic granules that stained both in a basic
tone, i.e. blue, and in a tone different from that of the dye employed, reddish-purple
(described by Michels, 1 963; see also Fig 3). Mast cell subtypes have further been
defined using various histochemical stains (Enerback, 1 986; Bienstock et aI. 1 986;
Kitamura, 1 989). Rodent mast cells have commonly been divided into two groups:
"connective tissue mast cells" to describe mast cells observed in connective tissues,
serosal cavities and the lung, while "mucosal mast cells" are those derived from the
lamina propria of the gastrointestinal tract. Both connective tissue type mast cells and
mucosal tissue type mast cells stain with alcian blue, while only connective tissue-type
mast cells stain with safranin or berberine sulfate (Enerback, 1 986; Bienstock et a1. 1 986;
Kitamura, 1 989). These subclassifications are useful for describing mast cells on the basis
of phenotype, but in reality they cannot be used to describe mast cells as being of a
specific tissue location because both types can be found in a particular anatomical site.
Fetal Mast Cells. Most observations of fetal mast cells have been reported in the

rat. In spite of the longer gestation time of rats (average of 22 days) compared to mice
(20 days), the first granulated mast cells generally appear at day 1 5 of gestation in both
species (Appendix, Table 6). However, using in situ hybridization, one report places Kit
expression by "likely" mast cells in para-sagittal sections of the buccal area at day 1 4 in
the mouse (Orr-urtreger et a!. 1 990). This corresponds to the first definite sighting of cells
with metachromatic mast cell granules at day 1 5 in mouse facial skin (Luke, 1 988). In
contrast, in the day 1 5 rat, mast cells are first seen in the mesenchyme ventral to the brain,
in the liver, the spleen, and the subcutaneous connective tissue (Combs, 1 965). In
addition, although granulated mast cells are never observed in the blood of normal adults,
they have recently been observed in embryonic murine blood 1 5. 5 days post coitus, after
which their numbers decline (Rodewald, 1 996). Mast cells are also observed in the
mesenteric connective tissue in the day 1 6 rat and by day 17 can be found in the
peritoneal fluid. In fact by day 1 8, over 20% of the cells in the rat peritoneal fluid are
granulated mast cells (Hagihara, 1 960). Having established when and at what sites
6
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granulated mast cells were found in the developing fetus, the quest then was for the
source of the un-granulated mast cell progenitor. When it was discovered that adult mast
cell progenitors, like adult hemopoietic cell progenitors could be found in the bone
marrow (Kitamura et al. 1 977), the search naturally turned to those embryonic tissue sites,
viz, yolk sac and fetal liver, that had been shown to contain hemopoietic cells progenitors.
Hemopoiesis and Mastopoesis in the Embryonic Yolk Sac and Fetal Lliver.

Although the connection between hemopoiesis and mastopoiesis was not known at the
time, the first evidence regarding the source of embryonic mast cell progenitors came
from an investigation in 1 970 by Moore and Metcalf. By that time, three assay methods
for murine YS, blood, and FL cells had been developed: (I) by counting colonies formed
in an in vivo spleen colony assay (CFU-Ss) (Till and McCulloch, 1 96 1 ), (2) by counting
colonies formed in in vitro culture in semi-solid media (CFU-Cs) (Bradley and Metcalf,
1 966), and (3) by testing the ability of cells to rescue a lethally irradiated adult (Tyan and
Herzenberg, 1 968). In addition, whole embryos and yolk sac explants could be cultured.
Moore and Owen had discovered that hemopoietic stem cells developed in avian YS
blood islands and then migrated and colonized other sites ( 1 967a,b). In their classic 1 970
paper, Moore and Metcalf first described the normal development of the murine Y S and
FL: " the YS first appears on d7 as the central part of the egg cylinder wall and grows so
rapidly that by d8, it has formed an extra-embryonic membrane surrounding the embryo.
During this same period, the YS blood islands appear in the mesodermal layer in contact
with the extra-embryonic endoderm. From d8 to d 1 2, erythroblasts can be identified by
their reddish appearance in the blood islands. No other hemopoietic type cell can be
identified during this period even if the cells are stained with hemopoietic cell stains. A
contracting heart, together with an extensive capillary network, is constructed by d9, so
that blood cells circulate between the YS and the embryo". Simultaneously, the
endoderm of the embryonic liver invades the loose sinusoidal network of the vitelline
veins and the septum transversum (see also the introduction), so that by diD the liver is a
distinct hemopoietic organ in its own right. Histologically, the liver consists of
undifferentiated parenchymal elements in intimate contact with circulating erythroid cells
(Wilson, 1 963). Besides undifferentiated blast-type cells, the liver contains
erythroblasts, myeloblasts, myelocytes and early megakaryocytes.
Moore and Metcalf assayed daily from d7 to d l 3 for the site of first appearance
and the numbers of hemopoietic cell precursors. In the YS, colony precursors rose and
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fel l from d8 to d 1 2, whether they were measured as number of colonies cultured in vitro
(CFU-Cs) or assayed in vivo (CFU-Ss). The maximum number of YS colony precursors

in vitro occurred at d 1 0, that in vivo at d 1 1 . Neither method demonstrated precursors
after d 1 3 in the YS. The in vitro assay was more sensitive with regard to first appearance
of precursors. For example, it detected precursors in the YS at d7, a day earlier than their
detection using the in vivo spleen colony assay. As few as 1 CFU-C could be detected in
a d7 YS, but in the circulation, no CFU-Cs were found until d9, when approximately 3 0
CFU-Cs per embryo were circulating. Blood CFU-Cs rose to a maximum o f 68 at d l O,
then dropped to about 30 again at d 1 1 , and then to 5 at d 1 2 and d 1 3 , the same level that is
maintained throughout adult life. CFU-Cs first appear in the FL at d 1 0 one day later than
in the circulation. They divide so rapidly that at d 1 1 there are 1 00 times as many as at d 1 0
and their numbers continue to increase through d 1 3 . The conclusions were obvious:
hemopoietic progenitors first arose in the YS and migrated via the circulation to the FL.
Moore and Metcalf also found that in vitro CFU-Cs were first found in the body of the
embryo at d9, and implied they had migrated there via the circulation from the YS.
Their findings marked the beginnings of many investigations that cultured cells
from the dissected yolk sac and fetal liver (Evans and Kaufman, 1 98 1 ). Most of these
studies were directed toward determining what kind of growth factor cocktail would
efficiently grow out the most hemopoietic lineages. Some investigators tried to isolate
and maintain the hemopoietic stem cell from embryonic tissues. Strictly speaking, in the
sense of a cell that is self-renewing and can differentiate only to hemopoietic cells, this
has not been accomplished, although there have been many claims of success. The
closest approximation are the embryonic stem cells from the inner cell mass which are
self-renewing in culture but are also pluri-potential and can differentiate into all cell
lineages, not only into hemopoietic cells (see below). Another offshoot of Moore and
Metcalf's work was the exploring of embryonic blood as a source of hemopoietic
progenitors. Large erythroid colonies were obtained by culturing d9 circulating peripheral
blood cells in methy1cellulose with adult spleen cell-conditioned medium and
erythropoietin (Wong et a1. 1 982).
Although both YS and FL cells were cultured by innumerable investigators for
hemopoietic progenitors, apparently no one cultured YS cells to observe mast cell
progenitors until 1 999 (Palis et al.), and it wasn't until 1 979 that Kitamura and his
colleagues examined FL cells for mast cell progenitors. At that time, an in vitro assay for
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mast cell progenitors had not been developed, but Kitamura et al. had developed an in

vivo assay based upon the easily distinguished giant mast cell granules of beige (Chediak
Higashi syndrome) mice. By transplanting FL cells from these mice to irradiated wild
type C57BLl6 mice, they were able to identifY mast cell progenitors in d 1 2 FL, three days
before mast cells themselves could be found in any embryonic tissue. They thus
concluded that mast cell progenitors, like hemopoietic progenitors, develop in the FL and
migrate through the circulation to other tissues.
In 1 983, Kitamura and his colleagues published a classic in vivo study that used
murine YS and FL cells to demonstrate that mast cell ontogeny parallels erythrocyte
ontogeny and to extend basic concepts of embryonic mast cell development. They used
WWV mice which have a natural mutation that causes them to lack dermal connective
tissue mast cells and to be anemic. They demonstrated that wild-type YS and FL cells
would differentiate into mast cells if injected into the skin of WW" mice. They also
determined the concentration of mast cell progenitors in the YS by enumerating mast
cells in measured skin sections of WW" mice that had been injected with wild type Y S
cells from different days o f gestation. They found more skin mast cell progenitors i n day
1 1 YSs than in day 9.5 YSs (Sonoda et al. 1 983).
The first report of in vitro culture of FL mast cell progenitors was by Razin et al.
in 1 984 who cultured FL cells using T-cell conditioned medium. They demonstrated that
FL derived mast cells had the same biochemical characteristics as mast cells cloned from
the BM. Seldin et al. (1986), using IL-3 rich media, also cloned mast cells with
characteristic phenotypes from human FL. Then in 1 988 Pharr and Ogawa determined
that FL cells cultured with IL-3 yielded more mast cells (and erythrocytes) than fetal
spleen cells from mice treated with 5-fluorouracil. By 1 992, SCF had been cloned (see
below) and mast cells were derived from human FL cells in suspension culture with SCF
the only added cytokine (Irani et al. 1 992). Recently FL cells have been useful in
studying the effect of IL-4 on mast cell progenitor proliferation (Nilsson et al. 1 994; Ryan
et al. 1 998).
A I S day-post-coitus fetal blood promastocyte that exhibits high Kit expression
and low Thy- l expression has recently been described. Interestingly, this promastocyte
was not found in the fetal liver (Rodewald, 1 996).
Hemopoiesis in the Paraaortic Splanchnopleura and the Aorta Gonadal
Mesonephros. As described above, the successful culture by Moore and Metcalf in 1 970
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of hemopoietic progenitors from YS and FL focused attention for years on these two
easily-dissected embryonic structures. Tn addition, their reasoning that CFU-Cs found in
the body of the embryo at d9 had migrated there via the circulation from the YS led to
dogma that the YS was the sole source of hemopoietic progenitors, in spite of an
occasional repoti such as that by Ogawa et a!. (1 988) that "the B cell progenitor . . . first
becomes detectable in the day 9.5 embryonal body rather than in the YS." Recent
findings that all hemopoietic stem cells arise in the para-aortic splanchnopleuralaorta
gonadal mesonephros regions inside the developing embryo, itself, and not in the YS,
challenged this dogma (for review, see Dzierzak, 1 998). The PAS/AGM region is located
in the abdominal region of the embryo and includes the splanchnic mesoderm, dorsal
aorta, genital ridges/gonads and pro/mesonephros, surrounding mesenchyme, and some
intermediate mesoderm. The discovery of the hemopoietic nature of the PAS/AGM
region was prompted by regional grafting experiments in the early development of avians
and amphibians (Cormier and Dieterlen-Lievre, 1 988). These experiments suggested that
a region inside the embryo was important in the early generation of definitive
hemopoietic stem cells, in spite of the fact that no erythropoiesis could be observed there
so early in gestation in the mammalian embryo. The murine experiments culminated by
demonstrating that definitive hemopoietic stem cells initiate autonomously and
exclusively within the AGM region (Medvinsky, 1 996).
However, these conclusions have been challenged in 1 999 by Palis et a!. who
were able to culture both primitive and definitive erythrocyte progenitors and macrophage
progenitors from the YS, and not from the PAS, before blood circulation was established.
This controversy will be addressed in the Discussion section.
In vitro Differentiation of Embryonic Stem Cells. Doetschman et a!. ( 1 985)
were the first to demonstrate that certain hemopoietic cells could be cultured ii-om cells of
the murine inner cell mass, the embryonic stem cells. This discovery led to three lines of
endeavor: ( 1 ) to extend the range to other hemopoietic cell lineages, (2) to detect
hemopoietic progenitor cells in various stages of differentiation, and (3) to examine the
kinetics of expression of the genes relevant to hemopoiesis. It took six years however, for
these lines of endeavor to bear fruit. Initially ES cells had to be co-cultured with cells to
retain their stem cell property. Then it was discovered that ES cells could be cultured
without co-culture using leukemia inhibitory factor (LIF) to prevent differentiation.
Schmitt et a!. ( 1 99 1 ) investigated cytokine and receptor gene expression during early ES
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cell differentiation. They found strong transcriptional activation, in a well-defined
temporal order, of many hemopoietic genes including erythropoietin, IL-4, and the
beta-globins, as well as the receptors for erythropoietin and IL-4. IL-3 message was not
expressed dW'ing the first 24 days of ES cell differentiation. In contrast, the message for
SCF was expressed early, and underwent substantial up-regulation during this period of
differentiation. The message for its receptor, Kit, was expressed relatively constantly
throughout the culture period. Burkert et al. ( 1 99 1 ) found that colonies of six lineages,
including mast cells could be cultured from ES cells in semisolid medium. Wiles and
Keller ( 1 99 1 ) were also able to culture multiple hemopoietic lineages from ES cells.
Keller et al. ( 1 993) demonstrated that the onset of hemopoietic markers within EBs
parallels those found in the embryo. Nakano et al. ( 1 994) were able to culture lympho
hematopoietic cells from ES cells. Kennedy et al. ( 1 997) described a common precursor
for primitive erythropoiesis and definitive hemopoiesis derived by culturing ES cells with
vascular endothelial growth factor and SCF. These findings were extended to the YS,
the whole embryo, the FL as well as EBs generated from ES cells by Kabrun et al. ( 1 997)
who found that all of the earliest embryonic hemopoietic precursors express Flk- l , the
receptor for vascular endothelial growth factor.
Kinetics of Kit and SCF in Embryological Development. Kit is a type III

receptor tyrosine kinase that is crucial for proper development of multiple organ systems.
Kit expression has been well-studied in the mouse oocyte and embryo. Oocytes express
Kit, as does the I -cell fertilized ovum. Kit could not be detected in embryos at the 4-cell,
or S-cell stage, nor up to and including the morula stage (Horie et al. 1 99 1 ). However,
the cells of the inner cell mass at d4.5 are positive for Kit mRNA. At days 6.5 and 7.5,
Kit+ cells are observed in the yolk sac and in parental decidua tissue, but still not in the
embryo proper (Orr-urtreger et al. 1 990; Bernex et al. 1 996). Amazingly, one day later,
at dS .5, three times as much message for Kit is found in the embryo as in the yolk sac
(Keller et al. 1 993). At the same time, numerous ectodermal (neural tube, sensory
placodes) and endodermal (embryonic gut) derivatives express Kit, as shown by in situ
hybridization (Orr-urtreger et al. 1 990). These cells could be elegantly followed during
development by Bernex et al. who introduced a mutation at the W (Kit locus which
contained the lacZ reporter gene. They confirmed that by dS.5, Kit+ cells are observed on
cells near the neural tube, and possibly also on the primordial germ cells in the allantois
(tubulal' diverticulum of the hindgut). The cells near the neural tube migrate to the
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dermis, while the primordial germ cells migrate to the gonads. At d9.5 , cells expressing
high concentrations of Kit are observed in the PAS, mostly on the ventral part of the
aorta. They seem to cross the ventral aOliic endothelium and directly enter the blood, so
these are probably the hemopoietic stem cells migrating to the fetal liver via the blood
stream (Bernex et al. 1 996).
We do not know however, if the mast cell stem cell is following only the blood
stream route or if it might also be using an "overland" (over cells and extracellular
matrix, see below) route to some sites. Observations which have been made on Kit+
melanoblasts (but not on promastocytes) suggest this possibility: By d9, melanoblast
progenitors have been identified migrating between the ectoderm and the dorsal somite
surface in the trunk and tail of the mouse. High concentrations of membrane stem cell
factor can be observed at d l 0.5 in the dorsal region of somites over which the
melanoblast progenitors are migrating (Matsui et al. 1 990). Mature melanoblasts also
appear simultaneously at d 1 0.5 on both sides of the neural tube, being first seen in the
head then in the trunk and then the tail. Melanoblast precursors that do not express Kit
cannot migrate (Bernex et al. 1 996). By dI2.5, dermal cells can be observed expressing
stem cell factor (Matsui et aI. l 990). By d 1 4 individual melanoblasts and/or mast cells
express Kit in sub-epidermal spaces in the tail, nose, buccal area and the face (Orr
urtreger et aI. 1 990), and by dI5.5, melanoblasts and mast cells have reached most of the
ventral dermis, but not the distal parts of the limb buds and the tail tip. Kit expression is
required for survival of mast cells in the dermis (Bernex et al. 1 996). Thus, it would
appear that the path followed by the Kit+ melanoblast progenitor might also be used by
the Kit+ mast cell progenitor to reach the dermis.
The Kit primordial germ cell is another cell type that migrates but does not do so
in the blood: It is not entirely clear whether the Kit+ cells observed in the allantois and
the foregut endothelium at d9 are primordial germ cells because of the presence in these
structures of other cells. However it has been observed that mesodermal cells along what
will become the migratory pathway of primordial germ cells express stem cell factor at
this stage. There is a gradient of SCF expression by cells from the dorsal mesentery, the
dorsal aorta, and the genital ridges (mesodermal swellings in the roof of the abdominal
cavity). Dorsal mesentery cells express less SCF then cells within the genital ridges,
while cells near the dorsal aOlia express intermediate amounts of SCF. It is thought that
primordial germ cells originate in the allantois and migrate through the dorsal mesentery
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and from the dorsal aorta to the genital ridges. At d l O, the greatest number o f Kit
expressing cells is in the vicinity of the dorsal aorta, and by d 1 1 .5, Kit cells have reached
the genital ridges. d 12.5 genital ridge primordial germ cells have very high Kit
expression. Once primordial germ cell colonization of the genital ridge is complete, the
gradient of SCF expression along the path disappears and SCF transcripts are confined to
the developing gonad. Sperm, like oocytes, also express Kit. In sum, there is ample
evidence that Kit+ progenitors have the ability to migrate throughout the developing fetus
via cell and extracellular contact, in addition to the circulatory route.
Culture of Mast Cells and the Cytokines, SCF and IL-3. There are three

systems for culturing mast cell progenitors in vitro: liquid culture, semi-solid media such
as methylcellulose, and co-culture with fibroblasts (Huff and Lantz, I 997a). Liquid
culture yields large numbers of mast cells, but has the disadvantage of not controlling
well the effects of paracrine growth factors from bystander cells. Methylcellulose
minimizes these effects and lends itself to the determination of the potentiality of
progenitors (see results), but yields relatively few cells. Fibroblast monolayers promote
quick and vigorous mast cell differentiation and most closely resemble the in vivo micro
environment, but the mature mast cells are bound to another cell, the fibroblasts. All
these systems require the addition of SCF and IL-3 for mast cell development, except for
co-culture with fibroblasts which requires only IL-3, because SCF is secreted by
fibroblasts and also is found inserted in their membrane (see below).
In 1 970, when Moore and Metcalf wanted a source of colony growth factors to
culture hemopoietic progenitors, they had to use pooled mouse sera or semi-purified
factors from human urine! Obviously the present-day availability of recombinant growth
factors has greatly simplified the culture of progenitors.
The discovery of SCF followed from clues which made use of natural mutants in
both the Kit gene, W, and the gene for SCF, Sl (Jarboe and Huff, 1 989a), and the
observation that mast cell-fibroblast interactions had long been suspected to play an
important role in mast cell development (see Swieter et al. 1 992 for review). Studies with
W or Sl mutant mice provided strong biological evidence that fibroblasts were a source of
a mast cell growth factor which existed both in soluble (Jarboe and Huff, 1 989b) and
membrane-bound forms (Fujita et al 1 988a, Fujita et al. 1 988b). Using the proliferation
of mast cells as their primaIY bioassay, several groups successfully cloned and
characterized the novel cytokine, SCF (see Galli et al. 1 993 for an interesting summary of
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this phase o f SCF's history).
IL-3 is a 20kDa disulfide bridged glycoprotein and was one of the earliest
characterized cytokines. It was found to promote differentiation and proliferation of
multiple hemopoietic lineages in addition to mast cells (see Lindemann and MertelsmaJll,
1 993 for review). Other cytokines, such as IL-4, IL-9, IL-I 0, and nerve growth factor,
have been reported to be involved in a synergistic manner with IL-3 in mast cell
differentiation and proliferation, but SCF and IL-3 have been shown to be sufficient to
develop mast cells from BM cells (Lantz aJld Huff, 1 995).
The Mast Cell Ontogenetic Markers, FCERI, and Tl. The classic stimulus of

mast cell activation is triggered by the interaction of specific antigen with IgE pre-bound
to mast cell membrane Fc receptors. The high affinity receptor for IgE is FCERI and it has
been established that as mast cell progenitors mature, they begin to express FCERI (but
studies of the progenitor from different sites conflict as to whether the receptor is
expressed before or after granule formation (Lantz and Huff, 1 995; Rodewald, 1 996).
The effect of IL-4 on the development of FCERI from BM mast cell progenitors cannot be
studied because mast cells completely fail to develop when BM progenitors are cultured
with IL-4 (Ryan et al. J 998). In contrast, the inhibition of FL-derived, FCERI-expressing
mast cells can be studied, apparently due to slower kinetics of mast cells differentiating
from FL cells than from BM cells (Nilsson et al. 1 994; Ryan et al. 1 998).
TI is a membrane molecule expressed both by immature and mature mast cells
whose structure resembles that of the IL- I receptor molecules (Moritz et al. 1 998). The
ligand for TI has not been found and its biological role is unknown, although recently it
has been found to be stably expressed by Th2 T lymphocytes, in contrast to Thl T
lymphocytes (Xu et al. 1 999). Because its structure places it in the faJnily of Toll family
receptors, T 1 has been speculated to play a role in innate immunity. It is expressed by
mast cells cultured from adult bone marrow cells and by fetal blood promastocytes, but
not by fetal liver cells (Moritz et al. 1 998). The expression of the T1 gene in mast cells is
GATA dependent (Gachter T, 1 998).
The Role of the Sodium-Ion/Hydrogen-Ion Exchanger in Cell Proliferation.

Cells regulate their intracellular pH by several different mechanisms. One of these is the
sodium -ionlhydrogen-ion exchanger (Na+/H+ X). The Na+/H+ X (also called an anti
pOlter) exchanges sodium and hydrogen ions with a stoichiometry of I : 1 in a direction
governed solely by the concentration of these ions on each side of the outer membrane.
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The Na+/H+ X is expressed in all eucaJyotic cells and functions primarily in intracellular
pH and cellular volume regulation. These processes have been shown to be intimately
related to several other cellular events including cell cycle control and differentiation.
The exchanger can be activated by a variety of mitogenic and non-mitogenic signals
including growth factors, hormones, chemotactic peptides, lectins, phorbol esters, and
even osmotic change (Greinstein et al. 1 989). At physiological pH the exchanger is
normally quiescent. When it becomes activated, an influx of sodium ions with a
concomitant efflux of hydrogen ions occurs, thereby resulting in a transient increase in
the intracellular pH. This process is inhibited by a potassium-sparing diuretic, amiloride,
and its analogs (Benos, 1 988; Kleyman and Cragoe, 1 988).
In addition to activation by growth factors and the other compounds mentioned
above, the exchanger can be activated merely by the interaction of extracellular matrix
molecules with their ligands. This is shown by controlling the sbape and proliferation of
endothelial cells by varying the density pattern of fibronectin coated on the culture plate
(Chen et al. 1 997). A cell which is constrained to a 30 [Lm2 fibronectin surface aJ'ea
rounds up and undergoes G 1 arrest, but a cell that can spread out over 80 [Lm2 , flattens
aJld proliferates. If an 80 [Lm2 area of tibronectin has an intermittent irregular pattern, the
cell attaches with the typical dendritic shape and proliferates, showing that binding of
equal numbers of fibronectin receptors is the critical determinant of cell cycle control
(Huang and Ingber, 1 999). When Ingber et al. (1 990) determined the intracellular pH of
endothelial cells as the cells progressed from rounded up to spread out as the fibronectin
coating area increased, they found rapid intracellular alkalinization. Thus, over the time
course of cell spreading, intracellulaJ' pH increased. The increase in intracellular pH also
correlated with increased DNA synthesis. Furthermore, all of these effects could be
suppressed by a specific inhibitor (ethylisopropyl-amiloride) of the membrane sodiwn
ion/hydrogen-ion exchanger (Ingber et al. 1 990). On the other hand, they could not get
these effects simply by varying the pH of the mediun1. They could show that they could
get these effects by clustering and immobilizing the cell membrane integrin ct5�1 which
binds fibronectin, and so concluded that an extracellular matrix receptor can behave
similarly to some growth factor receptors to activate a signaling pathway implicated in
growth control. They next discovered that other endothelial cell integrins binding to other
extracellular molecules, e.g., laJllinin, vitronectin and collagens types III, IV, and V, could
induce elevation of intracellular pH. Treatment ofT lymphocytes with an antibody
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against integrins has also been found to increase intracellular pH. Specifically, an anti
a L P 2 (LFA- I ) induced a rise in pH of peripheral human T cells, as did an antibody to the
T cell receptor complex (Schwartz, 1 99 1 ). More recently, this integrin-induced
proliferation in Go endothelial cells has been correlated with the transcription of the
mRNAs of the immediate-early genes, c-fos, c-myc, and c-jun, suggesting a mechanism
for the increased DNA synthesis observed earlier. Inhibition of the sodium ion/hydrogen
ion exchanger prevented most of the fibronectin-induced increase in c-jun expression, but
this inhibition was ineffective if the endothelial cells were stimulated by both fibronectin
and fibroblast growth factor (Dike and Ingber, 1 996).
The possible role of integrins and the sodium-ion/hydrogen-ion exchanger in the
proliferation of bone marrow cells has been further elucidated by Rich and his colleagues
( 1 998). They studied the effects of incubating ex vivo mouse bone man·ow cells packed
into a volume consistent with that found in vivo in the femur. This incubation could only
be done for 30 minutes; longer incubation times resulted in acidification of the medium
and cell death. However, this brief incubation time was apparently enough to affect DNA
synthesis because they found that if the incubated cells were subsequently cultured in
methylcellulose, they proliferated more than cells which had not been incubated at such
high density. Taking into account the findings by Ingber et al. described above, Rich et
al. tried adding either a sodium ion/hydrogen ion inhibitor or antibodies specific for
growth factors, for integrins or for extracellular-matrix molecules to the incubating cells.
They found three that at least partially inhibited the proliferation: hexamethylene
amiloride, anti-a" and anti-fibronectin, suggesting that the same pathways that were
activated in endothelial cells described above were activated in BM cells when they were
incubated at high density.
Extracellular Matrix Molecules. Although extracellular matrix molecules are

part of the microenvironment of all cells, their function is only partially understood. An
example is fibronectin, an adhesive glycoprotein known to stimulate cell migration which
is widespread throughout the embryo at the time when many cell migrations are
occurring. It has two classes of cell-surface receptors. One class of receptors is
exemplified by two integrins, a, p , and as p , (see below). A second class of receptor
molecules is provided by cell-surface heparan sulfate proteoglycans, which can bind FN
at an as yet undefined site within the so-called heparan-binding region. As described in
the introduction, gastrulation begins with the outer epithelial sheet cells secreting a
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fibronectin-rich matrix on their inner face over which primary mesenchymal cells crawl.
Migration involves four stages: timing of start, stimulation of migration, guidance and
cessation of movement. Fibronectin seems to play a role in more than one of these
stages. It has been shown to stimulate migration as well as to be involved in its timing,
the latter conclusion based on observations of alterations in its adhesiveness over time.
These alterations correlate with expression of different fibronectin splice-variants
(ffrench-Constant et al. 1 992). There is ample evidence that fibronectin is involved in
migration, but its role in proliferation has not been well studied. Other extracellular
matrix molecules which might play a role in mast cell development are laminin and
vitronectin (see below).
Illtegrills. Integrins are a family of "adhesion" molecules found in cell

membranes. "Adhesion" is a misnomer if it is taken to mean that cells use adhesion
molecules to permanently bind to each other and to extracellular matrix molecules
Throughout a typical cell's life specific adhesion molecules appear and disappear,
followed by the appearance of other specific adhesion molecules. In fact, we frequently
rely on these molecular kinetics to identify cells and follow their maturation. The role of
"adhesion" molecules in signal transduction is irrefutable. These points might best be
made by pointing out that, by these criteria, the T-cell and the B-cell receptors are
"adhesion" molecules!
Normal expression of adhesion molecules is absolutely crucial during
development and throughout life. The example of adherence to fibronectin has been
described above. Other examples are the cadherins which are another family of
adhesion molecule that functions at cell-cell junctions in early embryonic cells. To be a
typical hemopoietic or mast cell, however, these cell junctions must be replaced by
adhesion molecules of the integrin superfamily. In addition, to be a typical mast cell,
continued expression of Kit, a member of the protein kinase superfamily is necessary (see
above).
The integrins are heterodimeric transmembrane proteins composed by matching at
least eleven different alpha chains with seven beta chains. The large alpha chain (M.W.,
1 50,000 to 200,000) has several cation-binding sites (usually occupied by calcium or
magnesium ions) and is paired non-covalently with the smaller beta chain (M.W.,
90,000). The alpha subunit is composed of 7 tandem repeats of 60 amino acids and is
similar to the calcium binding proteins calmodulin and troponin. Different alpha subunits
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have different divalent cation binding preferences. The alpha subunit is usually made
initially as a single polypeptide chain, which is then cleaved into one small
transmembrane chain and one large extracellular chain that remain held together by a
disulfide bond.

Some alpha subunits are also constitutively phosphorylyzed. The short

cytoplasmic tail of the alpha subunit interacts with cytoskeletal proteins, which are known
to regulate motility of the cell. These cytoskeletal proteins can also serve to stimulate cell
proliferation, presumably through signaling to cell cycle proteins. The extracellular part
of the beta subunit has a cysteine-rich domain and extensive intra-chain disulfide bonding
which is important for its tertiary structure. In its resting condition, an integrin exists in a
relatively inactive conformation, rendering the cell comparatively nonadhesive.
However, it is the presence or absence of adhesive forces on a cell which determine its
three dimensional shape and the mechanical tension on its cytoskeletal molecules.
Recently, integrins have been discovered to play important roles in three crucial cellular
phenomena in addition to motility: differentiation, proliferation, and quiescence
(Oostendorp and Dormer, 1 997).
The integrins are expressed on a wide variety of cell types besides mast cells,
including lymphocytes, macrophages, fibroblasts, endothelial and epithelial cells where
they modulate the cell's capacity to bind to both membrane molecules on other cells and
defined sequences of extracellular matrix molecules and, in addition are involved in
differentiation ("activation") and proliferation.

P I ' has been shown to be required for the appearance of
P I deficient mice, stem cells are found in the yolk
sac and in the blood stream, but not in fetal liver (Hirsch et a!. 1 996). P I deficient cells
can form hemopoietic colonies if cultured in vitro, indicating that P I is not required at this
One integrin subunit,

hemopoietic stem cells in the liver. In

stage of embryonic development for hemopoiesis (at least in vitro).
Integrins require both an alpha subunit and a beta subunit for binding their ligand.
A common alpha subunit for

P I is a. (VLA-4).

Hamamura et al. (1 996) studied the

effect of blocking anti-a4 on hemopoietic progenitors of the fetal liver. They
administered a. antibody to pregnant mice from the seventh day of pregnancy to the day
of analysis and found that the antibody transmigrated into the embryos, including into the
fetal liver. Normal fetal liver hemopoietic mononuclear cells express both a4 and Kit.
They found one-third as much Kit expression by the treated 1 5 day fetal liver hemopoietic
mononuclear cells as expressed by the untreated cells. Hematoxylin and eosin staining
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of the treated livers revealed the absence of erytlu·oblast colonies normally seen in fetal
livers, but the number of myeloid colonies was unaffected. This lack of red blood cell
differentiation continued in the neonates, as evidenced both by their pale appearance and
a red blood cell count one-fifth that of normal neonates. However their white blood cell
count was normal. These data suggest that signaling through the 0:4 of hemopoietic
progenitor cells in fetal liver is crucial for differentiation of erythrocytes, but is not
required for myelocyte differentiation.
The Role of Integrins in Motility and Development of Mast Cells Derived
from Bone Marrow Cells. The technical ability to culture mast cells from BM cells

together with the characterization of adhesion molecules on leucocytes led to the
investigation of these molecules on mast cells. Dr. Metcalfe and his collaborators have
applied techniques that have been developed to study leucocytes and their attachment to
ECM molecules to the study of the attachment of adult, mature mast cells to the ECM
molecules, laminin, fibronectin, and vitronectin. For example, they reported that when
mast cells, which have been derived from BM cells, are cultured with IL-3 for one week,
they transcribe RNA for the laminin receptor (Thompson et al. 1 989). They have
identified a6 as the mast cell integrin subunit that binds laminin (Vliagoftis et al. 1 997)
and have determined IKYAY as the amino acid sequence in the laminin A chain that
mediates mast cell attachment and spreading (Thompson et a1. l 99 1 ). Subsequent
findings that FCERI-mediated signals stimulate mast cells to attach to and migrate on
laminin and fibronectin pointed to a possible role of mast cell integrins in the
accumulation of mast cells at sites of infection, inflammation, and wound healing
(Thompson et al. 1 993). These roles were further substantiated by the finding that an
acute phase protein found during infection, serum amyloid A, binds extracellular matrix
components and preferentially induces mast cell adhesion (Hershkoviz et al. 1 997). BM
cultured mast cells had to be activated by PMA for them to bind the RGDS attachment
site of fibronectin (Dastych et aI. 1 99 1 ). The binding of mast cells to fibronectin can also
be modulated by binding of low affinity mast cell IgG receptors by aggregated IgG; in
fact, the FcR gamma chain is an absolute requirement for this binding (Dastych et
aI. 1 997). In other experiments, it was found that culture in SCF also caused mast cells to
adhere to fibronectin (Dastych et al. 1 994). Curiously, SCF enhances the adherence and
migration on fibronectin even of mast cells from WWv mice whose Kit receptor has a
naturally mutated cytoplasmic chain. The Kit receptor in these mast cells could transduce
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a PI3-kinase-independent signal and in so doing, these mast cells retained their ability to
adhere to and migrate on fibronectin (Dastych et al. 1 998). However mast cells bind
plate-bound vitronectin more strongly than plate-bound laminin or fibronectin (Bianchine
et al. 1 992). Vitronectin binding was inhibited by anti-u V P3 (Bianchine et al. 1 992).
More recently they have found that either FCERl crosslinking or adherence to vitronectin
enhance phosphorylation of the signaling complex dubbed "focal adhesion kinase" (FAK)
(Bhattachryya et al. 1 999).

(The focal adhesion kinase complex is associated with

molecules of the cytoskeleton, such as actin). In addition they have found that the
molecules that form intercellular connections (gap junction cOlU1exins) are also expressed
on mast cells, conveying to them the potential to communicate with other cells such as
fibroblasts (Vliagoftis et al. 1 999). So it is clear that communication and signal
transduction through connexins and integrins are very likely important for the motility
and functioning of mature mast cells. One of the findings of the Metcalf group that might
be relevant to this thesis is that adherence to vitronectin increases proliferation of mature
mast cells (Bhattachryya et al. 1 999)
Studies of integrin expression of developing mast cells have been done by the
Weis group. The specific communication molecules that have been primarily implicated
in mastopoiesis by them are the integrins

Ct4P I and Ct.P7.

They reported that 76% of B M

cells express the Ct. integrin subunit after the cells have been cultured i n IL-3 alone for
one week. After 2 and 3 weeks,

Ct. expression increased to 91 % and then dropped to 85%

(Gurish, 1 992). If BM cells were cultured in both SCF and IL-3, or in SCF or IL-3 alone,
they found that the relative amounts of Ct.,

P I and P7 were modulated depending on the

cytokine(s) (Ducharme, 1 992). In another experiment, when they compared the RNA
differential display between mast cells cultured from BM cells in either IL-3 or SCF, they
discovered a novel

P2-like integrin subunit RNA dubbed "pactolus" tl1at was

preferentially transcribed in SCF-cultured cells (Chen, 1 998). A comparison of pactolus
RNA expression in various tissues such as spleen, kidney, lung, heart, thymus and the
small intestine versus ex vivo BM cells, revealed that only BM cells transcribed
significant amounts of pacto Ius RNA, implying that pactolus was an integrin subunit
involved in hemopoiesis and not a subunit involved uniquely in mastopoiesis, and also
implying that pactolus may be a molecule like Kit, which only mast cells retain after
differentiation. Although these studies suggest that integrin subunits may be important in
mast cell differentiation, they do not address early mast cell differentiation directly.

Materials and Methods
Isolation of Fetal Dermal Cells. Fetuses were placed in a dry Petri dish, and the

head, tail and appendages severed and discarded. Then a continuous, subcutaneous incision
anteriorly and posteriorly in the saggital plane was made using iris scissors. Using fine
toothed forceps, the embryonic skin was peeled away in two large, intact pieces. The pieces
were put into a 50-ml tube with HBSS and shaken vigorously several times, then the pieces
were transfened to a Petri dish with HBSS and minced into small sections. Next the minced
skin was trypsinized with 0.25% trypsin at 37° for 45 minutes using a 1 25-ml flask. The
trypsinate was carefully pipetted and transferred so as not to include clumps of undigested
tissue. The washed cells were then cytospun onto a slide and stained with 0.2% toluidine
blue, pH 2.8.
Preparation of Methylcellulose. 3% methyl cellulose was prepared as described in
Huff and Lantz ( 1 997a).
Preparation of 20% Bovine Serum Albumin. 20% bovine serum albumin was
prepared as described in Huff and Lantz ( 1 997a).
Clonal Culture of Cells. ES-D3 cells (ATCC) or ES-E 1 4TG2A cells (ATCC) were

placed in 1 500 U Leukemia Inhibitory Factor (LIF) (Sigma) per ml of " ES Media". DMEM
with 30% Embryonic Stem Cell Fetal Bovine Serum (Gibco-BRL), 1 % Bovine Serum
4
Albumin, 1 0UIl Oug penicillin/streptomycin, 2 mM glutamine, 0. 1 M HEPES, 5 X 1 0. M
2-mercaptoethanol, in a tissue culture flask coated with Type A 300 Bloom gelatin (Sigma),
and incubated in an atmosphere of5% CO2 and 5% 02. To form embryoid bodies (EBs), the
LIF was washed from the cells and the cells were placed in 1 ml of 2X ES Media
supplemented with 200 ng recombinant Stem Cell Factor (rSCF) (Biosource) and 200 ngrIL3 (Biosource), vot1exed with 1 ml 3% 4000 centipoise methylcellulose (MeC) (Fisher
Scientific) and incubated in 35 mm Petri dishes as above for 1 2- 1 3 days. The EBs were then
individually transferred to a well of a 96-well tissue culture plate containing 1 00 f.ll ES
media, 1 00 ng/ml rSCF and 1 00 ng/ml rIL-3 and incubated as above for 1 2 or more days.
Adherent and non-adherent cells were then cytospun, stained and phenotyped.
To obtain embryonic tissues, 8- 1 0 week old BALB/c mice (National Cancer Institute)
were mated overnight and the morning of vaginal plug observation assigned day zero (dO)
of gestation. At 8, 9, 1 0 and 1 1 days of gestation, YSs were dissected from the embryo,
washed free of maternal blood, and the cells disaggregated by gently drawing through a 20gauge needle 30 times. The disaggregated cells were washed with HBSS and cultured in
21
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MeC with rSCF and rIL-3 as above. (In some experiments, YS cells were cultured in MeC
with added transferrin, insulin and erythropoietin, and FL cells were cultured in Methocult
GF M3434, (StemCell Technologies, Vancouver, BC), both as noted.
Fetal livers were dissected after 14 days of gestation, and the tissue disaggregated as
above after grinding between the frosted-ends of two sterile microscope slides.

The

disaggregated cells were washed with HBSS, erythrolysis was performed and the remaining
cells were cultured in MeC with rSCF and rIL-3 as above.
Bone marrow cells were obtained by flushing femurs with a syringe of media and a
220- 1 y" needle as described in Huff and Lantz ( 1 997a). After washing and erythrolysis, the
remaining cells were cultmed in MeC with rSCF and r1L-3 as above.
Co-cultmes consisted of BALB 3T3 fibroblasts (ATCC) which had grown to
confluency in 3S mm tissue culture dishes cultured with YS cells or BM cells using ES
media supplemented with 1 00 ng/ml of rlL-3 and incubated as above (Huff and Lantz,
1 997a).
Staining ofMeC Cololliesfor Cytochemical Analysis. Single colonies were lifted

from MeC with a 1 00 fl.1 Pipetman, placed in 0.2 ml HBSS and spun in a cyto-centrifuge
(Cytospin, Shandon Southern) at 600 rpm for 6 min.

Slides were stained with May

Grunwald followed by counter-staining with Oiemsa to identify multi-lineage colonies. A
colony was scored as uni-potential-mast cell if only mast cells were seen, uni-potential-other
if the colony contained cells of only one lineage that was not mast cell and multi-potential
if it contained more than one lineage.
To characterize mast cells, slides or co-culture dishes were stained with 0.2%
toluidine blue, pH 2.8, berberine sulfate or alcian-blue-safranin (Huff and Lantz, 1 997b).
Fluorocytometric Analyses.

Fluorocytometric analysis ofFCER! surface expression on ex vivo cells and
on derived mast cells. Cells were analyzed ex vivo or cultured as described in the Fig
legends. To detect FCERl, the cells were first incubated for 30 min at 4°C with unlabeled
anti bodies 2.402 (Pharmingen) and B3B4 (Phalmingen) to block low-affinity binding ofIgE
(Huff and Lantz, 1 997b). After removal of excess blocking antibodies, halfofthe cells were
incubated with mouse IgE for 30 min at 4°C and washed. All cells were then stained with
FITC rat anti-mouse 19E. Propidium iodide was added to the cells to gate out dead cells and
they were examined using a Becton Dickinson FACScan flow cytometer (Becton Dickinson
1mmunocytometry Systems, Braintree, MA).

Fluorocytometric Analysis ofTl surface expression on YS, FL, and EMKit+
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cells. Ex vivo cells and derived mast cells were incubated with a rat antibody against the TI
surface antigen (DJ8, a gift ofDr R. Klemenz) (10 ug/ml) for 3 0 min at 4°C. Cells were then
washed and incubated with a FITC-Iabeled F(ab')2 goat anti-rat IgG for 30 min. After
washing, cells were stained with biotin-labeled anti-Kit ( I Oug/ml) for 25 min at 4°C,
followed by a Streptaviding-phycoerythrin (PE) conjugate (I Oug/ml) for 30 min at 4°C. In
all cases, 1 00,000 cells were examined per sample using a Becton-Dickinson FACScan Flow
Cytometer. Putative dead cells were excluded by forward and side scatter and spectral
overlap was corrected with electronic compensation.

Fluorocytometric analysis for a4 surface expression by YS cells. 5 X 1 0 5 cells
were incubated with rat anti-mouse a4 (Pharmingen) and 5 X 1 0 5 cells were incubated with
an isotype antibody control, rat anti-mouse IgG2b at 4° for 30 min. After removal of excess
antibodies, each sample was stained with anti-rat conj ugated FITC at 4° for 30 min. After
staining with propidium iodide to allow the gating out of dead cells, the relative number of
cells fluorescing in the FITC channel for each sample was recorded and compared.
Illcubatillg Cells at High Density (HCDI). Cells harvested as described above from

the YS, FL or BM were incubated when possible at a density found naturally in the bone
marrow (4 X 1 0 8/ml). To do this, cells were pelleted in one well of a 96-well plate and
incubated at 37" for 30 min. (Cells at such high concentration may be incubated for only 3 0
minutes due to limited availability o f nutrients and acid buildup (decrease in pH) in the
media). For a control, cells were incubated at low density ( l 05/ml) (LCD!) for 30 minutes.
After washing, both samples were counted and re-cultured in methylcellulose at usual density
(5 X J 04/ml) so that effects of HCD! on both proliferation and differentiation could be
measured. To determine if a hydrogen ion/sodium ion exchanger was involved in the effects
ofHCD!, an inhibitor ofthis exchanger ( 1 00 j.lM 5-(N,N-hexamethylene) amiloride) (AMIL)
(Sigma) was added to a duplicate well of cells. To determine if signaling through the a4
subunit of the integrin, VLA4, was involved in the effects of HCDl, an antibody to a4
(Pharmingen) was added to a duplicate well of cells.

After 8 days of culture in

methylcellulose, the number of colonies were counted, the colonies transferred to slides and
stained with May-Griinwald-Giemsa to identify the lineages which had differentiated.
Isolatioll ofKit'Lilleage' FL cells. After erythrolysis, FL or BM cells were incubated

with rat Abs Mac- I , Gr- I and B220 ( 1 0 ug/ml each) for 30 min at 4°. After washing, the
cells were incubated with Dynabead M-450 immunomagnetic beads coated with sheep anti
rat IgG (Dynal, Great Neck, NY) for 40 min at 4°. The majority of mature hemopoietic cells
were then removed using a magnetic particle concentrator (Dynal). The remaining cells were
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stained with phycoerythrin (PE)-Iabeled F(ab')2 goat anti-rat IgG ( 1 0 ug/ml) for 30 min at
4° to detect residual lineage positive cells. Cells were washed and stained with biotin-labeled
anti-Kit ( 1 0 ug/ml) for 25 min at 4°. Finally, after washing, the cells were stained with a
streptavidin-quantum red conjugate ( 1 0 ug/ml) (Sigma Chemical Co., St. Louis, MO) for 30
min at 4°. Kit+, lineage negative cells were then isolated by two-color fluorescent sorting
using the flow cytometer Coulter Elite ESP (Coulter Corp., Hialeah, FL), for use in the
determination of the potentiality of Kit' FL cells and the intracellular pH of Kit' BM cells
as they bind fibroblasts.
Determination of Intracellular pH Using Fluorescent Ratio Imaging.

A

monolayer of fibroblasts was prepared by culturing BALB 3T3 fibroblasts (ATCC) grown
to confluency in 35 mm tissue culture dishes. Kit+ BM cells were loaded with a lipid soluble
ester dye, 25 �M 2', 7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl
ester, (Molecular Probes, Eugene, OR) at 4°. The dye was washed from the cells and both
the BM cells and the fibroblast monolayer were brought to room temperature to prevent pH
changes due to temperature changes before the BM cells were added to the monolayer. After
focusing on cells which had settled on fibroblasts using a 40X objective of a light microscope
and imaging with a setup consisting of a cooled CCD camera (Imago, TILL photonics,
Applied Scientific Instrumentation, Eugene, OR) attached to an image intensifier (VS4- l 845
Videoscope, Washington, DC), an epifluorescence light source (Polychrome IVC, Till
Photonics, a 5 1 5 run beam splitter, and a 535 nm emission filter (both from Omega Optical,
Brattleboro, Vermont). The cells were alternately excited at 490 run and 440 run and imaged
at 1 0 s intervals. The relative pH of the cells over time was recorded by measuring the ratio
of the fluorescence intensities at these two wavelengths using TILLvisION v3 . 1 imaging
software. (Inside the cell, an esterase cleaves the ester releasing a charged fluorescent dye.
The dye shows an excitation or emission spectral shift when it binds a hydrogen ion or fails
to bind one, as the case may be.

By measuring a ratio, artifactual variations in the

fluorescence signal that might otherwise be misinterpreted as changes in ion concentration
are cancelled). Background levels were subtracted from the fluorescent measurements by
the software before calculation of the ratio. Calibration was accomplished by adding cell
permeable acidic and then alkaline solutions of known pH and measuring the fluorescence
ratio at both extremes. The calibration curve was constructed using Sigma Plot 5 .

RESULTS

Mast cells arefound ill tile 15d dermis, but not in tile 1 4d dermis. We first checked

that mast cells were developing in the fetuses of the strain of mouse we wanted to use in our
comparative mast cell progenitor studies. We found that if the dermis was dissected from
d l 4 and d i S embryos, the d i S trypsinated dermal cells contained .03% mast cells.

In

contrast, hardly any (.002S%) of the d l 4 dermal cells were mast cells. These results agree
with Luke ( 1 988) who described the first appearance of granulated mast cells at d i S of
gestation in the facial skin of the mouse.
Botll yolk sac cells and cellsfrom the embryo properform colonies when cultured
with SCF and IL-3. We found that the number of colonies formed per YS cell cultured with

SCF and IL-3 depends on the day of gestation (Fig I ) . We also found that these recombinant
cytokines also generated colonies from the embryo, itself (Fig I ). Although both the YS and
the embryo contained cells capable of forming colonies at days 8 and 9 of gestation, the
number of colonies on a per cell basis of both increased dran1atically at 1 0 days of gestation
(Fig I ). We chose day 1 0 of gestation yolk sac cells for the majority of our experiments
Only mast cell progenitors differentiate wilen cells from embryollic tissues are
cultured with SCF alld /L-3. Embryoid bodies (EBs) formed by ES cells and colonies

formed by YS, FL, the embryo, or BM cells were microscopically visible after 3 days of
culture in MeC. Enumeration of the EBs and of the colonies after 1 2 days of culture found
that ES cells differentiate into the largest number of colonies (EBs) on a per cell basis (Table

I). While ES cells, embryo cells, and YS cells differentiate only to mast cells, adult B M
progenitors differentiate both to single lineage and to multi-lineage colonies containing
ample numbers of cells (Fig 2). Both YS and embryo cells yielded only mast cell colonies
from gestation 8 through gestation day I I (Table 2). However, the lineage potential ofFL
cells was difficult to determine (Table 2, and see also next section). Finally, an experiment
that directly compared the potentiality of YS cells and BM cells, confirmed that YS cells,
when cultured with SCF and IL-3, formed only mast cell colonies, while BM cells formed

2S

26

Figure I : NlUll ber of colonies from the YS and the embryo proper. Cells were cultured in
MeC with 100 U/ml IL-3 and 1 00 nglml SCF for 1 2 days. In each experiment the number
of colonies per 1 06 cells for triplicate cultures was determined. YS yolk sac colonies; E
colonies from cells of the embryo itself, without the yolk sac.
=

=
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TABLE 1: NUMBER OF COLONIES FROM VARIOUS PROGENITOR
SOURCES

PROGENITOR
SOURCE

n

COLONIES/I06
CELLS

ES-D3

4

*8400 ± 420

ES-EI 4

3

* 850 ± 2 1 2

8d YS

3

7±4

8d Embryo

3

2 ± 0.9

9d YS

3

IS ± 3

9d Embryo

3

8±3

1 0d YS

12

489 ± 1 05

1 0d Embryo

4

407 ± 204

l i d YS

3

402 ± 1 47

l i d Embryo

3

675

+
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5 X 1 0' ES cells were cultured in MeC with 1 00 ng/ml SCF and 1 00 ng/ml lL- 3 for 1 2
days and the * EBs (here called "colonies") formed were counted. 1 05 Y S and Embryo
Proper cells were cultured in MeC for 1 2 days and the colonies formed were counted. n
equals the number of experiments.

29

Figure 2. Potentiality of precursors from YS and BM compared directly. d I D YS cells and
adult BM cells were cultured separately, but simultaneously in the same batch ofrSCF- and
rIL-3-supplemented ES media and MeC under the same conditions. After 1 2 days of culture,
single colonies were transfelTed to cytospin funnels, cytospun and stained with May
Griinwald-Giemsa. 96 colonies from each tissue were examined and 1 00 cells of each colony
were examined and identified to determine if the colony was a pure mast cell colony or if it
contained cells of other lineages. Fig 2 shows results of culturing YS and BM cells
simultaneously under the same conditions (and includes ES cell and embryo cell colony data
solely for comparison purposes).
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TABLE 2: LINEAGE PHENOTYPE OF COLONIES GENERATED FROM
VARIOUS CELL SOURCES

Colony Phenotype
Cell
Source

n

Number
of
Colonies
Scored

ES-D3

4

ES-EI 4

Unilineage
Mast
Cell

Multilineage with
Mast Cells

Multilineage (no
Mast Cells)

18

18

0

0

0

3

65

65

0

0

0

8d YS

3

57

55

2

0

0

8d Embryo

2

5

5

0

0

0

9d YS

3

1 39

139

0

0

0

9d Embryo

3

74

74

0

0

0

1 0d YS

12

341

341

0

0

0

1 0d
Embtyo

4

1 14

1 14

0

0

0

l I d YS

3

79

79

0

0

0

0

0

Other Unilinage
Colonies

l id
Embryo

3

34

34

0

1 4d FL

6

130

31

98

I

0

Adult BM

8

121

52

66

2

10

E S cells were cultured in MeC with 1 00ng/ml SCF and 1 00ng/ml lL-3 for 1 2- 1 3 days.
'EBs (here called colonies) were individually transferred to liquid media and incubated
with the same concentrations of SCF and lL-3 for 1 2 days. YS, Embryo, FL, and BM
cells were cultured in MeC with SCF and lL-3 for 12 days and individual colonies
pipeted from the MeC. Picked colonies were cytospun, stained with May-Grunwald
Giemsa and phenotyped. n equals the number of experiments. Number of colonies is ±
SE of the mean.
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mixed lineage colonies (Fig 2 shows results o f culturing YS and B M cells simultaneously
under the same conditions and includes ES cell and embryo cell colony data solely for
comparison purposes).
Are FL progenitors uni- or mlllti-potential when cllltured with SCF and IL-3?

Table 2 indicates that a large prop0l1ion of 1 30 FL colonies were "multi-lineage with mast
cells", while one was multi-lineage without mast cells.

The former colonies actually

contained numerous mast cells, some erythrocytes and erythrocyte progenitors with a small
percentage of macrophages (0. 1 % to 0.3%), which qualified them as multi-lineage colonies,
but we suspected that the macrophages were erythrocyte "feeder cells", cells that form the
central cell of a BM blood island and provide the iron for the production of hemoglobin, and
that take in unwanted nuclei during the enucleation phase of erythrocyte maturation (Vogt
et al. 1 99 1 ). To examine this possibility, we sorted FL cells for Kit+Mac- progenitors, and
these formed pure mast cell colonies in methylcellulose. We then compared the potentiality
of ex vivo FL cells with that of s0l1ed Kit+Mac-cells using a broader range of cytokines found
in Methocult (SCF plus IL-3 plus erythropoietin plus IL-6). We found that the ex vivo FL
cells developed into many lineages (mast cells, erythrocyte progenitors, erythrocytes and
neutrophils), whereas only mast cell colonies differentiated from sorted Kit+ cells, indicating
that, by sorting for a Kit+ progenitor, we had isolated a committed mast cell progenitor and
probably not isolated progenitors of other lineages. The potentiality results of ES, YS, and
FL cells together with the results obtained with control BM cells results, are summarized in
Table 3 .
Cells cultured from embryonic cell progellitors display characteristic mast cell
phellotypes. The granules of ES-derived cells stain metachromatically with toluidine blue

as is typical of mast cells (Fig 3, top). Tf ES derived cells are stained with May-Grunwald
Giemsa, which would detect cells of other hemopoietic lineages, no other lineages than mast
cells are observed (Fig 3, bottom). Cells derived from cultured dl 0 YS cells also express
granules that are positive for toludine blue (Fig 4, top), berberine sulfate (mast cell
proteoglycan) (Fig 4, bottom), and alcian-blue-safranin (connective-tissue type mast cells)

33

TABLE 3: POTENTIALITY OF ES, YS, FL, AND BM CELLS WITH
DIFFERENT CYTOKINES

Cytokines

SCF
and
1L-3

EPO,
SCF,
and
1L-3

ES Cells

YS Cells

Unipotential:

FL Cells

B M Cells

Ex vivo

K+Mac-

Ex vivo

K+Mac-

Unipotential:

Bipotential:

Unipotential:

Multipotential:

Multipotential:

Mast
Cells

Mast
Cells

Mast Cells
and RBCs

Mast
Cells

Mast Cells
PMNs
Macs

Mast Cells
PMNs
Macs

Multipotential:

Multipotential:

Multipotential:

Unipotential:

Multipotential:

Multipotential:

Burkert et
al. ( 1 99 1 )

Mast
Cells
PMNs
Macs
RBCs

Mast Cells
PMNs
Macs
RBCs

Mast
Cells

Mast Cells
PMNs
Macs
RBCs

Mast Cells
PMNs
Macs
RBCs
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Figure 3, top: Cells of Colonies Differentiated From ES Progenitors Stain Positively For
Mast Cell Characteristics: Cells from EBs from ES-D3 cells cultured for 25 days with SCF
and IL-3 in MeC were transferred to a slide and stained with toludine blue. Clearly visible
are the discrete, metachromatic granules, deep blue cytoplasm and eccentric nucleus typical
of mast cells.
Figure 3, bottom: May-Grunwald-Giemsa staining ofES-D3 derived cells reveals only mast
cells and no cells of the erythrocyte, neutrophil, or monocyte lineage.
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Figure 4, top: Cells from a dlO YS colony display characteristic mast cell granules with
toludine blue staining.
Figure 4, bottom: Berberine sulfate causes mast cell proteoglycan granules to fluoresce in
a cell from a d l O YS cell colony.
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Figure 5, top: Alcian-blue-safranin identifies the mast cells derived from d I 0 YS cells as
connective tissue-type mast cells and distinct from mucosal tissue-type mast cells.
Figure 5, bottom: Fc€RJ staining of d l O yolk sac derived mast cells determined by flow
cytometry. (--- ) indicates tbe cells stained with the negative isotype antibody control,
IgG2b. (
) indicates the cells stained with the antibody specific for Fc€RJ, IgE.
-
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(Fig 5. top). In addition mast cells derived from YS cells express the high affinity Fc
receptor for IgE, FCERl (Fig 5, bottom). (Mast cells derived from FL cells also express
FCERl (see below). May-Griinwald-Giemsa staining revealed there were no cells identifiable
as erythrocytes, neutrophils or macro phages (Figs 6 and 7).
Granule formation can be followed as YS cells are cultured.

Mast cells

differentiated after only 4 days of culture do not have the discrete granules that can be seen
after 5 days of culture (Fig 6, top, compared with Fig 6, bottom ). By 7 days of culture,
colonies contain cells with and without discrete granules (Fig 7, top). After 1 2 days of the
culture, the typical mature mast cell heavily laden with discrete granules predominates (Fig
7, bottom). All differentiated cells examined from colonies after 3 to 12 days of culture
appeared to be of mast cell and no other lineage.
If YS cells are CIlitllred with other cytokines, multiple lineages differelltiate. To

confirm that we could derive other lineages from yolk sac progenitors as reported by others
(reviewed in Dierzak and Medvinsky, 1 995), we cultured d l O YS cells in the presence of
additional cytokines or in fibroblast co-cultures (Fig 8). If d l O YS cells were cultured in
MeC with insulin, transferrin, erythropoietin and IL-3, multipotential progenitors
differentiated (Fig 8, top). When d l O YS cells were co-cultured with fibroblasts (a source
ofSCF and other cytokines) for 5 days, nucleated erythrocytes and neutrophils differentiated
(Fig 8, bottom).

However, after 1 2 days of co-culture, cells of the mast cell lineage

predominated (not shown).
Varyillg the concentrations ofseF and IL-3 does not affect the phenotype of YS
colony cells and demonstrates synergy ofthe number of colonies differelltiated by these
cytokilles.

Because different types of cultured hemopoietic cells deplete cytokines at

different rates and therefore exhibit concentration-dependent differences in growth (Zandstra
et al. 1 997), we varied the concentrations of SCF and TL-3 in our YS cell cultures. In this
way, we hoped to determine if the potentiality of YS cells could be changed from the mast
cell uni-potentially we had found when we cultured with 1 00 ng/ml ofSCF plus 1 00 ng/Illl
IL-3 Cfable 2). However, we found that even if the concentration of SCF was varied from
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Figures 6 and 7 . Granule formation can be followed as cultured mast cells mature: To
obtain colonies ofmast cells at different stages of maturation, 1 8 ml ofd I 0 YS cells in MeC
were distributed to 9 Petri dishes, and the colonies from one dish were plucked each day of
culture beginning with day 4. (After plucking colonies, the MeC was washed from the
remaining cells, which were stained and examined for other lineages).
Figure 6, top: Mast cells differentiated after four days of culture do not have discrete
granules.
Figure 6, bottom: After five days of culture, granules seem to be forming in the cell in the
middle. (continued on Fig 7)
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Figures 6 and 7.
(continued):

Granule formation can be followed as cultured mast cells mature

Figure 7, top: By seven days of culture, colonies contain mast cells with and without discrete
granules.
Figure 7, bottom: After 1 2 days of culture, mature mast cells display discrete, dense
granules.
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Figure 8: Other cytokines differentiate YS precursors to multiple lineages:
Figure 8, top: Cells of one of five colonies cultured from d l O YS cells in MeC with 3U/ml
of erythropoietin, 1 0 ug insulin/ml and 200 ug transferrin/ml for 5 days. In this colony,
nucleated erythrocytes (e), macro phages (m), neutrophils (n) and mast cells (mc) can be
identified.
Figure 8, bottom: Trypsinized cells from a 5 day coculture onT3 fibroblasts (f) and d I 0 YS
cells. A nucleated erythrocyte (e) and a neutrophil (n) have differentiated.
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o to 300 ng/ml relative to 0 to 1 00 nglml of rIL-3 in cultures of YS cells, if colonies

proliferated, those colonies were mast cell colonies (Table 4). If the total number of mast
cell colonies formed by each cytokine alone is compared to the number formed by SCF and
IL-3 together, synergy by the cytokines is seen (Fig 9). In addition to numbers of colonies,
synergism was also seen in colony size. very small colonies were formed by SCF alone,
small colonies by IL-3 alone, and very cellular colonies by SCF and IL-3 combined (data not
shown).
Determination of the expression of T1 on YS and FL cells. In collaboration with

Dr. G. Klisch, ex vivo cells from the 1 0d YS and the 1 4d FL were fluorescently stained with
anti-Kit and anti-TI . Significant numbers ofFL cells apparently expressed both Kit and n ,
but significant numbers o f Y S cells did not appear to express J(jt and TI (Fig 1 0).
The kinetics of expression of T1 on mast cells derivedfrom YS and BM cells. As

seen in Fig I I , as mast cell progenitors differentiate in culture from either the 1 0d YS or the
adult BM, they gain expression of n .
IL-4 inhibits FL-derived mast cell FCERI expression. Mature mast cells already

derived from BM cells have been shown to down-regulate FCERl expression, if cultured in
TL-4 (Ryan et al. 1 998). We investigated if lL-4 down-regulated the FCERl of mast cells as
they developed from FL cells. As seen in Figs 1 2 and 1 3 , the addition of IL-4 (in addition
to SCF and IL-3) to cultures ofFL cells caused down-regulation of FCERl expression at all
time points studied Approximately 99% of the cells after 23 days of culture were mature,
granulated mast cells.
Incubating YS cells at high density increases their proliferation via the hydrogen
ion/sodium ion exchanger, but does not appear to involve signaling through ex4• In this
series of experiments, we continued to compare the yolk sac cell mast cell progenitor with
the BM mast cell progenitor by comparing the effect on their proliferation of incubating them
at high cell density for a brief time. High cell density incubation of either BM or YS cells
caused increased proliferation in methylcellulose cultures (Fig 1 4). Proliferation of colonies
in the methylcellulose culture was decreased for both kinds of cells if an amiloride inhibitor
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TABLE 4. EFFECT OF VARIOUS CONCENTRATIONS OF SCF AND IL-3 ON
YS CELL COLONY NUMBERS AND PHENOTYPE

SCF
(ng/ml)

IL-3
(ng/ml)

n

COLONIESII 06 YS
CELLS

COLONY
PHENOTYPE

0

0

3

O±O

N/A

0

100

9

52 ± 8.2

Pure Mast Cell

10

0

3

O ± 0.9

N/A

10

2

3

72 ± 1 .9

Pure Mast Cell

10

50

3

1 06 ± 7.5

Pure Mast Cell

25

1 00

3

1 82 ± 90.8

Pure Mast Cell

50

1 00

3

239 ± 74.4

Pure Mast Cell

100

0

10

6 8 ± 18.5

Pure Mast Cell

1 00

25

3

1 7 1 ± 47.7

Pure Mast Cell

1 00

50

3

2 1 4 ± 95.8

Pure Mast Cell

100

100

10

240 ± 12.5

Pure Mast Cell

300

2

3

1 85

Pure Mast Cell

+

1 1 .5

d 10 YS cells were cultured in MeC for 12 days, then the colonies were enumerated and
the cells of selected colonies phenotyped. In each experiment, at least 6 colonies were
cytospun and the cells stained with May-Griinwald-Giemsa for phenotyping. The data in
the rows that are in bold are the data displayed in Fig 9. n number of experiments; NIA
Not Applicable; Number of colonies ±-SE of the mean.

=

=
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Figure 9. Synergy of SCF and IL-3 : dlO YS cells were cultured in MeC with 1 00 ng/ml
rSCF (SCF ) or 1 00 ng/ml r1L-3 (IL-3) or both 1 00 ng/ml rSCF plus 1 00 nglml rIL-3 (SCF
+ IL-3). After 12 days, the colonies for each category were counted, totaled, and the percent
of each category of the total determined. A bar showing the arithmetical sum (SUM) of the
percent colonies due to rSCF stimulation plus the percent due to r1L-3 stimulation is included
as a reference to demonstrate synergy.
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Figure 1 0 : T I expression on Kit+ ex vivo cells from d l O YS cells and d l 4 FL cells. Cells
were incubated with rat anti-TI (DJ8), followed by a FITC-labeled F(ab')2 goat anti-rat IgG.
Cells were washed and stained with biotin-labeled anti-Kit, followed by a Strepavidin
phycoerythrin (PE) conjugate.
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Figure I I Y S and BM cells gain expression ofT I a s they develop into mast cells. Cells from
the d l O YS (Top) and adult BM (bottom) were cultured in ES media and sampled on days
7, 1 4 and 2 1 . At each time point, cells were incubated with rat anti-Tl (DJ8), followed by
a FITC-labeled F(ab ' )2 goat anti-rat IgO. Then the cells were washed and stained with
biotin-labeled anti-Kit, followed by a Strepavidin-phycoerythrin (PE) conjugate.
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Figme 1 2 The effect ofIL-4 cultme on the expression of FCERl by FL derived mast cells.
Top: ex vivo FL cells do not express FCERJ. Ex vivo FL cells were stained with fluorescent
IgE Abs. Control cells were stained with an isotype Ab, IgG2b. Before cultme, the FL does
not contain sufficient numbers of mast cells to detect the expression of FCERl. Bottom:
after 7 days of culture mast cells expressing FCERl have increased in number but there is no
apparent difference in FCERI expression between those cultured with IL-4 and those cultured
without IL-4. (continued in Fig 1 3)
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Figure 1 3 The effect ofIL-4 culture o n F L derived mast cells (continued from F i g 1 2). Top:
after 14 days of culture, greater numbers of mast cells express FCER1 than after 7 days o f
culture, but there is still n o apparent difference i n FCERI expression between those cultured
with 1L-4 and those cultured without 1L-4. Bottom: after 23 days of culture, the number of
mast cells cultured without IL-4 that express FCERI are clearly greater than the number
cultured without IL-4.
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Figure 1 4 . High cell density incubation o f bone marrow cells (top graph) causes increased
proliferation in secondary cultures as measured by the number of colonies formed from cells
densely cultured ( I 0s/ml) in primary culture for 30 minutes (HCDC), compared to cells
cultured at low density ( J OS/ml) (LCDC), in primary culture for 3 0 minutes. Proliferation
of colonies in the secondary culture is decreased if an amiloride inhibitor (AMIL) of the
hydrogen ion/sodium ion exchanger is added to the high cell density primary culture. It is
also decreased by addition of an antibody to an integrin subunit, a, (ALPHA-4) to the high
cell density primary culture. High cell density incubation of YS cells (bottom graph) also
increases subsequent proliferation of colonies in secondalY culture and likewise this
proliferation is decreased if an inhibitor ofthe exchanger is added to the primary incubation
(AMIL). In contrast, addition of anti-a, to yolk sac cells during high cell density incubation
(ALPHA-4) did not significantly decrease and, in fact, had no effect on the increased
proliferation due to high density incubation.
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(AMIL) o f the hydrogen-ionlsodium-ion exchanger was added t o the high cell density
primary culture (FigI 4). It was also decreased by addition of an antibody to an integrin
subunit, C(4 in the case ofBM cells, but not for YS cells (Fig 1 4.). Fluorocytometric analysis
.

for the expression of C(4 by YS cells failed to detect C(4 positive cells (Fig 1 5).
High cell density incubatioll of YS cells, does /lot af
fect the phenotype of the
resultant cells.

High cell density culture of yolk sac cells did not change the limited

differentiation of progenitors to mast cells when cultured only with stem cell factor and IL-3,
that is, YS cells that had been incubated briefly at high cell density yielded only mast cell
colonies (data not shown).
Illcubating FL cells at high density also ill creases their proliferation.

We

continued our comparison of embryonic mast cell progenitors by studying the effect of high
cell density incubation on FL progenitors.

The proliferation of FL cells was greatly

augmented when they were incubated at high cell density. We found that the number of
proliferating progenitors following dense incubation of FL cells was more than double the
number following dense incubation of YS cells or BM cells (Fig 1 6).
The hydrogen-ion/sodium-ion exchanger is also activated when BM mast cell
progenitors first contact fibroblasts.

Reasoning that the high-cell-density incubation

model resembled a co-culture of mast cell progenitors with a fibroblast monolayer model,
we tested the effect ofamilori de on the subsequent proliferation ofmast cells as the mast cell
progenitor binds the fi broblasts during the first thirty minutes of contact. This model is more
specific to mast cell proliferation and also has the advantage of mimicking the in vivo
situation in which the mast cell progenitor migrates to connective tissue, where it matures
and proliferates. We found that, by preventing the activation of the hydrogen-ionlsodium
ion exchanger by adding amiloride during the first 30 min of co-culture of BM cells with
fibroblasts, fewer mast cell colonies developed after 5 days of culture, indicating that the
Na+/H+ exchanger is involved in the initial phase of intercalation ofBM mast cell progenitors
with fibroblasts (Fig 1 7).

62

Figure 1 5 . To compare the expression of a, on BM (top histogram) and YS cells (bottom
histogram), ex vivo BM and YS cells were stained with the isotype control antibody, IgG2b
biotin, or with anti-a4-biotin followed by staining of both with strep-avidin FITC so that
expression of a4 could be determined. Color key: red histograms anti-lX4 plus FITC; black
histograms isotype control antibody, IgG2b plus FITC. Computer subtraction of the
positive area (area to the right ofx 1 0') under each histogram indicated that 23% of bone
man-ow cells express lX4 (top panel) compared to 0% of yolk sac cells (bottom panel).
=

=

=
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Figure 1 6 A comparison ofthe effect of 30 min high cell density incubation of ex vivo YS,
FL, and BM cells on the subsequent percent increase in colony numbers in secondary MeC
cultures.
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Figure 1 7 The effect of the presence of a Na+/H+ X inhibitor (AMIL) during the first 30 min
of contact between 8M mast cell progenitors and a monolayer of 3T3 fibroblasts on the
development of mast cells after 5 days of culture. The first bar shows the number of mast
cell colonies per 50 fields when bone marrow cells were added to fibroblasts. The middle
bar shows the decrease in colonies if amiloride is added with the bone marrow cells only for
the first 30 min of co-culture. The bar on the right is a control in which the bone marrow
cells are incubated for 30 min with amiloride and then washed before being added to the co
culture. All dishes of progenitors and fibroblasts were incubated for 5 days following
treatment, when the mast cell colonies were stained with toluidine blue. The mast cell
colonies in 50 microscopic fields per dish were counted and the total number of colonies for
3 dishes/experiment determined. Data represent the mean and S.D. of three experiments.
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Fluorescent imaging of Kit+ BM cells as they bind fibroblasts confirms increase
in intracellular pH. Based on the results described in the previous section, it would be
hypothesized that the binding of a BM mast cell progenitor causes an activation of the
hydrogen-ionlsodium-ion exchanger that then exchanges cytoplasmic hydrogen ions for
extracellular sodium ions, with the result that the activation leads to a decrease in
cytoplasmic hydrogen ions, that is, a relative increase in pH within the progenitor.

In

addition, this alkalinization must subsequently stimulate those transduction mechanisms that
lead to the proliferation of the mast cell progenitor, because if the activation of the exchanger
is prevented, that is, if alkalinization is prevented by an inhibitor, proliferation is decreased
by 72% (Fig 1 7). We wanted to see if we could confirm this speculation in a more direct
manner by visualizing the intracellular pH change of a progenitor as it bound the fibroblast.
We chose sorted Kit BM cells to study because we reasoned that it was probably the Kit
ligand that was binding the SCF receptor in the fibroblast membrane as a prelude to
intercalation and proliferation. By loading the Kit+ cells with a fluorescent pH sensitive dye,
visualizing them using a fluorescent microscope, and recording the change in fluorescent dye
emission, we could follow the change in intracellular pH as 1 6 Kit+ cells bound the
fibroblasts (Fig 1 8-22). During a 20 min period, as the Kit cells settled on the fibroblast,
the cytoplasm of 12 of the cells became alkaline, with an average increase in pH of some of
0.64 pH units (Table 5 and Fig 22).

69

Figure 1 8 : Light micrograph of a dye-loaded Kit· BM cell (left of center) settling on a
monolayer bed of fibroblasts seen in background as somewhat triangular in shape.
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Dye-Loaded Cell with Fibroblasts in Backgro u n d
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Figure 19: The fluorescent field at lower magnification prior to fluorescence emission
analysis. About 16 cells can be seen (light areas), 1 2 ofwhich will be observed for a change
in intracellular pH as they contact fibroblasts.
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Lower Magnification Field Prior to Fluorescence
Emission Analysis
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Figure 20: Fluorescent image of the cells shown in Fig 20, indicating by green emission that
all dye-loaded cells are at physiological pH (found to be 7.44 ± 0.22 after calibration), except
for one cell near the center which is emitting in the red and is already too alkaline to be
included in the study, probably due to contacting a fibroblast before the preparation was
ready to be recorded (approximately 5 min).
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Cells Observed Under Fluorescent Light
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Figure 2 1 : Change of pH as 1 2 cells contact fibroblasts. Each line represents the pH of one
cell over a 20 min interval as it initially contacts a fibroblast. Traces on the right show the
intracellular pH of the same cells as the cells are loaded with permeable alkali (7.84) and acid
(6.54) solution. From this calibration, the intracellular pH can be calculated as listed in
Table 5, page 77.
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Table 5 CHANGE IN INTRACELLULAR pH DURING FIRST 20 MIN
AS BM CELL CONTACTS FIBROBLAST

=

Cell

time = 0

1

7.67

7.81

0.15

2

7.68

7.81

0.13

3

7.69

7.81

0.12

4

7.70

7.81

0. 1 1

time

20 min pH increase

5

7.41

7.83

0.43

6

7.43

7.81

0.38

7

7.44

7.79

0.35

8

7.52

7.82

0.30

9

7.10

7.84

0.74

10

7. 1 1

7.81

0,69

11

7.23

7.82

0.59

17

7.27

7.83

0�56

Group
#1

Range
0. 1 1

to

Mean

=

=

0.15
0.13

+ 0.01
#2

Range
0.30

=

to 0 . 4 3

Mean

=

0.36

+ 0.03

#3

Range

=

0,56 to 0.74

Mean

=

0,64

+ .04
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Figure 22: Graph showing three groups of cells each of whose mean pH change is
significantly different than the others: four with small changes in intracellular pH (mean
change 0. 1 3 pH units), four with intermediate changes in pH (mean change 0.36 pH
units), and four with large changes in pH (mean change 0.64 pH units).
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Discussion
The mast cell as a model for studying embryonic and fetal stem cells. The mast
cell model is a very potent model for studying proliferation and differentiation from stem
cells. The technical advantages that the mast cell model offers are at least threefold: ( I )
because stem cells and mast cell progenitors share a marker, Kit, purification of Kit cells
ensures that both stem cells and committed mast cell progenitors are separated from other
contaminating cells, (2) only two cytokines are required for mast cell differentiation and
robust proliferation, and (3) the mast cell progenitor and the mature mast cell are easily
assayed due to the presence of granules with stain specificity. Lantz and Huff ( 1 995)
developed this powerful model using adult tissue sites as sources for mast cell progenitors
and, for reasons given in the next paragraph, we wanted to use to it extend our studies of the
mast cell progenitor to embryonic and fetal mast cell progenitors.
We began with the notion that YS stem cells were different from FL and BM stem
cells with respect to their lineage potentiality. We were aware of classical findings that YS
cells, unlike FL and BM cells do not rescue an irradiated adult, i.e., YS cells do not form the
multi-lineages required to replace the hemopoietic repertoire. We also had in mind the
uniqueness of the erythrocyte in the YS, which is phenotypically and functionally different
from the FL and BM erythrocyte, by viltue of having a nucleus and a distinct form of
hemoglobin. We wondered if the YS mast cell would be as different as the YS erythrocyte,
which seemed possible based on findings of GATA transcription factors that had revealed
similarities between the erythrocytic and mast cell paths of differentiation (Orkin, 1 996). We
had also discovered that the effects of culture with SCF and IL-3 of BM and other adult
progenitors depended on the stage of maturation of the cells at the time of exposure to the
cytokines. We therefore speculated that embryonic and fetal mast cell progenitors might be
at different stages of maturation, so we set out to discover what might be revealed by a
comparison of ES, YS, FL, and BM mast cell progenitors cultured with SCF and IL- 3 . We
did find that YS cells yielded uni-potential colonies of mast cells, substantiating our
hypothesis that the mast cell progenitor of the YS was different from the multi-potential
progenitor of the BM. However, our nearly identical results with ES cells and FL cells gave
us pause for reflection. These results were, that, ES cells, which represent the epitome of
toti-potentially, were also uni-potential when cultured in SCF and IL-3 . In our hands, FL
80
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cells were also nearly uni-potential with SCF and IL-3. We reviewed pertinent papers and
concluded that the results of rescue experiments depend on the micro-environment of the
recipient. While it is true that YS cells cannot rescue an irradiated adult, wild-type d9 YS
cells can completely rescue Kit deficient WWV fetuses in utero (Toles et a1. 1 989) and d9
CD34+ YS cells can rescue lethally-conditioned neonates (Yoder et al. 1 997). This concept
that the fate of a stem cell depends both on its past history, i.e., its tissue site, and on its
future circumstances, i.e., the exogenous factors found in its new micro-environment have
been a matter of extensive recent discussion and will be commented on later. Now we want
to discuss, in detail, our findings regarding the differentiation of mast cell progenitors and
the proliferation of mast cells from different embryonic and fetal tissue sites.
The differentiation orES, YS, and embryo mast cell progenitors. We began our
comparisons of embryonic, fetal and bone marrow mast cell progenitors by analyzing the
colonies that develop when the cells are cultured in semi-solid media with SCF and IL-3 .
Our initial observations, regarding the earliest day of the presence of mature mast cells
confirmed the findings of Luke ( 1 988). As he had found, we also were able to stain mature
mast cells from the d 1 5 dermis, but not the d 1 4 dermis. Our initial findings that SCF and IL3 would differentiate mast cells from the inner cell mass cells (ES cells) and the YS extended
the concept that in the early embryo, ability to differentiate into mast cells parallels the ability
to differentiate into hemopoietic cells. In addition, we found the maximum number of YS
mast cell progenitor colonies in the d I 0 YS, as had Moore and Metcalf ( 1 970) using an in

vitro colony assay. Others have cultured mast cell progenitors from ES and YS cells using
cytokine cocktails (Burkert et al. 1 99 1 ; Palis et al. 1 999), but we were the first to discover
that culturing these cells with SCF and IL-3 alone was sufficient to yield mast cell colonies.
Not only are SCF and IL-3 sufficient to generate mast cell colonies, mast cell colonies are
the only lineage developed from ES and YS cells with SCF and IL-3 .
What does the development of just mast cells from ES and YS cells with only SCF
and IL-3 mean? Does it mean that SCF and IL-3 are directing the differentiation of only
mast cells progenitors from among the many progenitors arising from the stem cells, or that
only committed mast cell progenitors, and not other progenitors, are arising and being
selected for differentiation by SCF and IL-3? Surprisingly, trying to answer this apparently
simple question leads to consideration of a long-disputed controversy regarding stochastic
versus deterministic processes during lineage differentiation. When the periodical, Blood,
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launched a new featw-e called, "Controversies in Hematology", the first issue explored was
the question of "the mechanisms responsible for commitment of multi-potent hematopoietic
progenitors to cells ofeach blood lineage. Evidence from many quarters indicate that growth
factors are essential for hematopoietic development. However, the precise role played by
these proteins, whether to direct multi-potent cells down a particular cellular pathway or to
merely support the sw-vival of cells that have intrinsically selected a specific hematopoietic
lineage, remains controversial" (Kaushansky, 1 998).
In contrast to the unique erythrocyte that differentiates from YS cells (Fig 8), we
could not find any difference between the phenotype ofthe mast cells differentiated from YS
cells with that of mast cells differentiated from FL or BM cells. Ow- YS-derived mast cells
express the high affinity receptor for IgE, FCERI, and have granules that stain with alcian
blue-safranin, with berberine sulfate, and heterochromatically with toludine blue, all bona

fide characteristics of mature mast cells (Figs 4 and 5).
In agreement with the findings of Palis et al. (J 999), who cultw-ed mast cell
progenitors from d9-d 1 1 embryos, we found that recombinant cytokines also generated mast
cell colonies from the embryo itself. At each day of gestation tested, from d8 to d 1 1 , we
were able to culture mast cell progenitors from the embryo that had been dissected away
from the YS and FL. As with the YS, only mast cell colonies were differentiated by cultw-e
in SCF and IL-3 . These mast cell progenitors were probably from the PAS andlor AGM.
Palis et al. were able to culture both primitive and definitive erythrocyte and macrophage
progenitors from the YS, and not from the PAS, before blood circulation was established,
in contrast to the results of experiments by Medvinsky and Dzierzak ( 1 996, 1 998), who
demonstrated that definitive hemopoietic stem cells initiate autonomously and exclusively
within the AGM region (Medvinsky, 1 996). It should be noted that the experiments, which
lead to these contradictions with respect to the initial site of definitive hemopoietic stem
cells, are usingJlifferent assays upon which to base conclusions. Medvinsky and Dzierzak
use an in vivo spleen colony assay and an in vitro organ cuitw-e system, whereas Palis et al.
culture progenitors with cytokines and amplify hemopoietic marker messages. In view of
recent findings with regard to the plasticity of stem cells (reviewed by van der Kooy and
Weiss, 2000) and findings described earlier (Page 80) with respect to the impoltance of age
of recipient in determining stem cell potentiality, both of which emphasize the influence of
the new micro-environment on the fate of stem cells, it would seem to be prudent to take into
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account the different exogenous factors a stem cell encounters, in addition to its past history
(tissue site), before defining basic principles of hemopoietic stem cell development.
The differentiation of FL mast cell progenitors. We initially thought that the FL
would be the source of progenitors of many lineages including mast cells, erythrocytes,
macrophages and neutrophils, because these lineages are found in BM cell colonies cultured
in SCF and IL-3, and because FL and BM cells are well known for their ability to rescue
lethally irradiated recipients. However, we found that the majority of colonies from FL cells
cultured in SCF and IL-3 contained only mast cells, and erythrocyte-lineage cells, with a few
macrophage-like cells, similar to the center cell in the BM known as a "blood island" (Vogt
et al. J 9 9 1 ) . Blood islands are speculated to consist ofa macrophage-like central cell or cells
surrounded by differentiating erythrocytes, to provide iron for the production ofhemoglobin,
and to take in unwanted nuclei during the enucleation phase of erythrocyte maturation. We
investigated the possibility that the macrophages were nurses and not a differentiating lineage
by purifying KitMac- I ' cells from the FL cells. The Ki(Mac- I ' cells formed pure mast cell
colonies in methylcellulose with SCF and IL-3, confirming that the macrophage-like cells
we had found in colonies from ex vivo FL cells cultured with SCF and IL-3 were probably
nurturing cells for erythrocytes. These results contrasted with results that yielded colonies
of many lineages by culturing Kit+ BM cells with SCF and IL-3 (Lantz and Huff, 1 995).
We were surprised when we compared the lineages cultured from ex vivo FL cells and
sorted Kit+ FL cells using Methocult (SCF plus IL-3 plus erythropoietin plus IL-6). Multiple
lineages (mast cells, erythrocyte progenitors, erythrocytes, and neutrophils) developed as
expected from ex vivo FL cells, but only mast cell colonies developed from sorted Kit+ F L
cells, indicating that the Kit+ cell we were isolating was a committed mast cell progenitor and
not a multi-potential Ki( stem cell as expected. We entertained two possibilities to explain
why our Kit+ FL cells contained progenitors for no other lineage than mast cells. One
possibility was that we were introducing a technical artifact during the isolation procedure,
i.e., possibly the anti-Kit antibody was stimulating only mast cells and/or even killing
progenitors of other lineages. This possibility seemed unlikely because Kit+ cells from the
BM isolated by using the same anti-Kit antibody are multi-potential (Lantz and Huff, 1 995).
Another possibility was that Kit+ FL cells of day 14 of gestation were actually only
committed mast cell progenitors. We turned to the literature to discover if d 14 Kit+ cells had
ever been examined for multi-lineage progenitors.
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Apparently d l 4 Kit FL cells have never been cultured for multi-potential
progenitors. However an interesting result was observed in 1 98 1 , by Nabel and colleagues,
who incubated d l 3 FL cells in media conditioned by concanavalin A-activated BALB/c
spleen cells for 10 days and then transferred the FL cells to wells containing ilTadiated
syngeneic BM cells. After 1 0- 1 4 days, they observed that, "All colonies grown in these
conditions were composed of cells of similar appearance that resembled mast cells by light
microscopy because of their prominent metachromatic granules and expressed identical
profiles of surface membrane glycoproteins."

In other words, using Con A conditioned

media and irradiated BM cells, they generated pure mast cell colonies. These results could
be interpreted to mean that these conditions promote only the differentiation of uni-potential
mast cell progenitors from d 1 3 FL cells, or they could mean that Con A conditioned media
promoted differentiation of multiple lineages, indicating that some FL cells were stem cells
or at least were multi-potential, but that these failed to form colonies when transferred to
irradiated BM cells.

If these results show that these conditions promoted only the

differentiation of uni-potential mast cell progenitors from d 1 3 FL cells, they would be in
agreement with our findings on d 14

ex

vivo and Kit+ FL cells, especially if the failure to

develop erythrocytes was due to the absence of live BM cells to act as central blood island
nurses.
Although we could not find data directly relevant to d 14 Kit+ FL cells cultured in

vilro, data are available regarding the presence of Kit cells in the FL as it develops from d I I
to d i S and the rescue potential of these cells. Bernex et al. ( 1 996) followed the spatial and
temporal patterns of Kit expressing cells using a transgenic mouse model in which a lacZ
reporter gene had been inserted into the Kit gene so that the normal expression of Kit could
be followed. They found normal Kit expression in d l O to d l 2 FL cells, with an initial rise
at d I 0, a maximum at d I I and decreasing numbers from d 1 2 onward. Sanchez et al. ( 1 996)
determined the percentage of sorted Kit cells in d I 0, d I I , and d 1 2 FL cells to be 3%, 24%,
and I S%, respectively. Thus they also saw an initial rise, a maximum, and a decline in the
percent ofKit+ cells during FL development. These data point to the possibility that the d 1 4
F L has few, i fany, Kit+ cells (see next paragraph). (They also found that all hemopoetic stem
cells were in the Kit+, not the Kir cell population, an observation with respect to the Kit
marker made by others). They extended tl1eir observations to the multi-potentially of FL
cells by testing the ability ofFL cells to reconstitute irradiated mice. They were not able to
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reconstitute irradiated mice using d l O FL cells, but d 1 1 FL cells reconstituted 48% of the
mice while d l 2 FL cells reconstituted 93% of the mice. The reconstitution data cannot be
related to the percent Kit+ data because of the large differences of cell numbers inj ected for
each gestation day examined, but we can conclude that as of d 1 2, the FL contains Kit cells
that are multi-potential progenitors in vivo. This chronology can be extended with the data
of Morrison et al. ( 1 995). Depending on the number of d 1 4 (unsorted) FL cells injected, they
were able to reconstitute 90-1 00% of recipients. They also separated Kit+ d 1 2- 1 4 FL cells
and reconstituted 5 of 5 recipients. As these 5 recipients were injected with a range of
gestation day cells, we cannot draw conclusions with respect to d 14 cells, alone. So,
although it seems that the level of Kit+ expressing FL cells decreases after d I I , there are
multi-potent progenitors capable of rescuing irradiated mice in the FL at least until d l 2 of
gestation, and possibly at d 14. One reason for qualifying this statement lies in the possibility
that these investigators may not have been careful to separate the FL cells from fetal blood
cells.
The observations made by Rodewald et al. ( 1 996) emphasize the importance of
separating fetal blood cells from FL cells when conclusions about fetal progenitors are made.
Rodewald et al. studied fetal blood cell progenitors that express Kit and Thy1 and sorted a
KithThy l lO granulated pro mastocyte from the fetal blood at d 1 5. This cell was found to be
a committted mast cell progenitor because it would form pure mast cell colonies when
cultured with SCF and IL-3, but it would not form colonies of other lineages even with the
addition of cytokines known to develop other lineages (Rodewald et al. 1 996). In addition
to this uni-potential Kith;ThyllO mast cell progenitor, they could sort a KitThyl - multi
potential progenitor from fetal blood. When they searched for the origin of the blood
KithiThy 1 10 promastocyte, they wrote, "we could not identify a corresponding population in
fetal liver in mid or late gestation". It's not clear whether this means they found no Kit cells
in the FL, (which might be the case if the data about Kit described above are taken into
account), or if they could just not find Kith;Thy l lO promastocytes there. Regardless, it's
intriguing that their committed mast cell progenitor, which could be sorted from the blood,
and could be cultured to express FCER! and to display other mast cell phenotypes, including
rescue potential for mast cell deficient W/WV mice, could not be found in the fetal liver.
Perhaps this progenitor only acquires these characteristics after migration from the fetal liver
to the blood. Finding this progenitor only in fetal blood and not in FL does point up the
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necessity of interpreting data from the fetal liver cautiously. Unless one is careful to drain
the fetal liver of all its blood, conclusions with respect to mast cell progenitors in the fetal
liver may be tentative. We did not drain the fetal livers of blood so our results with respect
to finding that our KitMac-l ' progenitors formed only uni-potential mast cell colonies may
mean that we were somehow s0l1ing for Kith;Thy l lO progenitors, and not Kit+Thyl '
progenitors, even though an antibody to identify the Thyl marker was not used.
Tl and FCERl expression of developing mast cells. In view of our conclusions

above that we were studying not just FL cells but FL cells plus fetal blood cells, we should
amend our description of the results we obtained when we double-stained "FL" cells with
anti-Kit and anti-T l . We found Tl positive cells in the "FL" (Fig I 0). Moritz et al. ( 1 998)
observed weak expression of Tl by FL cells, whereas fetal blood promastocytes expressed
high levels of T I . Thus the relatively high level of TI expression by FL cells we observed
was probably due to a large number offetal blood cells. Ex vivo YS cells expressed little T l ,
but gained expression of T l concomitant with the expression of Kit as they matured into
mast cells, as did cultured BM cells (Fig I I ). Moritz et al. ( 1 998) also found that BM cells
gained expression ofTI as they became mast cells. Since it appears that TI is expressed as
progenitors mature into mast cells, and granules also form as mast cells mature, perhaps the
reason Kit+ FL (and blood) cells express TI and Kit+ YS and BM cells don't express Tl is
because the Kit+ FL (and blood) cells are granulated (Rodewald et al. 1 996), indicating they
are more mature, whereas the Kit YS and BM cells are not granulated and thus are less
mature (Klisch, 1 999).
Next, we wanted to study the effects of IL-4 on the expression of the high affinity
receptor for IgE, FCERI in differentiating FL mast cells and BM mast cells. However, BM
cells fail to develop into mast cells if they are cultured with IL-4. In contrast, if mature mast
cells, which have been derived from BM cells (without 1L-4), are cultured for four days with
IL-4, almost 50% of the cells lose FCERI expression (Ryan et al. 1 998). On the other hand,

ex vivo FL cells can be cultured with IL-4 and the inhibition of expression of FCERI
monitored as the cells become mast cells. Figures 12 and 13 show a progressive decrease
in FCERI expression as mast cells develop from FL cells.

Therefore, FL mast cell

progenitors differ from BM mast cell progenitors in the regulatory effect of IL-4 on FCERI
expression during mast cell maturation, but mature mast cells from the BM retain the
capacity of IL-4 regulation of FCERI expression exhibited by developing FL mast cell
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progenitors.
Factors affecting the proliferation of mast cell progenitors. As we were doing the
above comparative studies, we were intrigued to learn that a very short incubation of B M
cells at a high density could influence subsequent proliferation o f progenitors (Rich e t al.
1 998) and so we proceeded to extend our comparative study to the effect of high cell density
incubation on proliferation ofYS and FL cells. We discovered that the proliferation of both
YS and FL cells could be increased by briefincubation oftightly packed cells. The increased
proliferation of YS cells could be completely prevented if an inhibitor of the hydrogen
ion/sodium-ion exchanger was present dming the incubation, indicating possible
involvement ofthis exchanger with proliferation (Fig 1 4). Exchanger involvement had also
been observed with high cell density incubation of BM cells (Rich et aI. 1 998), and with
endothelial cells as they bind fibronectin (Ingber et aI. 1 990). In the latter experiments, the
increase in proliferation was accompanied by an increase in the transcription of the mRNAs
of the immediate-early genes, c-fos, c-myc, and c-jun, (Dike and Ingber, 1 996) and an
increase in DNA synthesis (Ingber et a!. 1 990). As Rich et a!. ( 1 998) were able to partially
inhibit proliferation of BM cells by addition of either an inhibitor of the hydrogen
ion/sodium-ion exchanger or an antibody to fibronectin, it appears likely that the
proliferation of BM cells and YS cells depends on activation of the exchanger and upon
binding of the cells to an extracellular matrix molecule
Although the proliferation of cells from the YS, the FL, and the BM could all be
increased by incubation at high density, cells from different sites had different magnitudes
of proliferative responses and different responses to an inhibitor of the Na+IH+ exchanger.
Amiloride was much more effective in preventing the proliferation of YS cells than it was
in preventing the proliferation ofBM cells after incubation at high cell density (Fig 1 4). The
proliferation of FL cells due to high cell density incubation was much greater than the
proliferation of YS and BM cells (Fig 1 6). The prevention of BM mast cell progenitor
proliferation in co-culture by amiloride was also greater than the prevention of proliferation
when BM mast cell progenitors were incubated at high cell density (Fig 1 4 and Fig 1 7).
Thus it appears that the Na+/H+ exchanger might play an even more important role in the
proliferation of YS and FL cells than it does in the proliferation ofBM cells.
Next, we wanted to study the involvement of the Na+/H+ exchanger in a model that
more closely approximates the micro-environment of differentiating mast cell progenitors
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in vivo. We chose to observe the effect of the presence of an exchanger inhibitor during the
first 30 min in which BM cells contacted cells of a dermal fibroblast line. We found a 75%
inhibition of subsequent proliferation due to the exchanger inhibitor (Fig 1 7). We reasoned
that if the hydrogen-ionlsodium-ion exchanger was being activated during this contact, a
change in intracellular pH must be occurring. To test this, we chose to exclude all BM cells
that did not express Kit, so as to limit our observations to cells that could bind the fibroblast
membrane SCF. By fluorescently imaging the Kit' BM cells during their first 20 min of
contact with the fibroblasts, we observed an intracellular pH changes in twelve cells, in
some cases by as much as 0.64 ± .04 pH units. Thus we have developed a model that can
kinetically follow the early events involved in signal transduction that lead to cell
proliferation.
Conclusion. Table 6 compares, in summary form, the results of our experiments
with cells from different tissue sites with respect to potentiality, expression ofTI and FCERI,
and proliferation. Recent findings in developmental biology have led to a re-thinking of the
concepts of stem cell, phenotype and mechanisms determining lineage potential (van der
Kooy and Weiss, 2000).

Stem cells are multi-potent, self-renewing cells that are

appropriately differentiated for their specific tissue niches. A cell ' s phenotype can be
described by a listing ofthe combinations of genes currently expressed, and lineage potential
is dependent on a cell's in vivo lineage history, while its further differentiation depends both
on that history and on exogenous factors present in its microenvironment. A comparison
of the results of our experiments with cells from different tissue sites with respect to
potentiality, and the expression of genes for Tl and FCERI is seen in Table 5. lt is obvious
that the progenitor niche site profoundly changes the lineage potential of these cells and that
their lineage is also influenced by the cytokines added to the cultures. Thus, by culturing
cells that are appropriately differentiated for their specific tissue niches, and observing their
ability to develop mast cel I phenotypes in new niches, we have demonstrated that the lineage
potential ofthese stem cells with respect to the mast cell lineage and other lineages is, in fact,
dependent on their in vivo history and on exogenous factors present in the microenvironment.

TABLE 6 :

RESULTS OBTAINED BY COMPARING E MBRYONIC, FETAL LIVER AND BM CELLS FOR DIFFERENT ATTRIBUTES

FL (and blood) Cells

BM Cells

Attribute

ES Cells

YS Cells
Ex vivo

K+Mac·

Ex vivo

K+Mac'

Potentiality with SCF and IL3

URi-potential,
Mast

Uni-potential,
Mast

Bi-potential.
Mast and
RBCs

Uni-potential, Mast

Multipotential

Multi-potential

Potentiality with EPO, SCF
and IL-3

Multi-potential
Burkert et al.
(1991)

Multi-potential

Multipotential

Un i-potential, Mast

Multipotential

Multi-potential

Increased proliferation if
incubated at high cell
density?

Not determined

Yes

Yes

Not determined

Yes

Not determined

HCDI Proliferation
attenuated by Amiloride?

Not determined

Yes

Yes

Not determined

Yes

Not determined

HCDI Proliferation
attenuated by anti-alpha 4?

Not determined

No

Not
determined

Not determined

Yes

Not determined

IL-4 decreases FCERJ
expression?

Not determined

Not determined

Yes

Not determined

Cannot Be
Detennined

Cannot Be
Determined

De /lova cells express Tl?

Not determined

No

Yes

Not determined

No

Not determined

T l expressed as mast cells
differentiate?

Not determined

Yes

Not
Applicable

Not determined

Yes

Not determined

Proliferation in Co-culture
attenuated by Amiloride?

Not determined

Not determined

Not
determined

Not determined

Yes

Not determined

Increase in intracellular pH
as ex vivo cells contact
fibr
�lasts?

Not determined

Not determined

Not
determined

Not determined

Not
determined

Yes
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Appendix A

7

TABLE

SPECIES

H ISTORICAL OBSERVATIONS OF FETAL MAST CELLS
(in chronological order)

DAY OF
G ESTATION

TISSUE

REFERENCE

Rat

day

15

Subcutaneous connective tissue.,
liver, spleen, unspecified organs

Maximow, A.,

Rat

day

19

Subcutaneous connective tissue

Laguesse,E.,

Rat

day

16

Subcutaneous connective tissue

Alfejew, Sophia,

1 924

Rat

day

17

Spleen, muscle, connective tissue ,
near joints, mediastinum, between
abdominal viscera

Alfejew, Sophia,

1 924

Rat

day

20

Stomach mucosa, lymph nodes

Alfejew, Sophia,

1 924

Rat

day

16

Subcutaneous connective tissue

Webb, R.L.,

Rat

day

16

Subcutaneous connective tissue

Holmgren,

1 907

1919

1 936

1 946

Rat

day

15

"en plein mesenchyme"

U rtubey L.,

Rat

day

16

Subcutaneous connective tissue

Arvy, L.,

Rat

day

17

Peritoneal Fluid

Hagihara, M.

Rat

day

15

Subcutaneous connective tissue, liver

Gamble, H.J. and
Stempak, J.G., 1 96 1

Rat

day

16

Mesentery connective tissue

Gamble, H.J. and
Stempak, J.G., 1 96 1

Rat

day

15

Mesenchyme ventral t o brain

Combs, J.W. et aI.,

Rat tail

In vitro

H uman

Week

Mouse

day

Mouse

Day

14

1 5 tail culture

1 948

1 956
1 960

1 965

Kiernan, J.A.,

1 974

Dermis, mesenchyme

BI'eathnach, A.S.,

15

Facial skin

Luke D.A.,

day

18

2 1 % o f peritoneal

Mouse

day

15

Dermis

Mouse

day 1 4 (exa�
day unclear

)

Blood

cells

1 978

1 988

Sasaki K. and
Matsumura G.,

1988

Bernex F. et al.,

1 996

Rodewald H R et aI.,

1996

Vita
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